Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

o ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: December 31, 2016

 

x TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from July 1, 2016 to December 31, 2016 (see explanatory note)

 

Commission File No. 333-191175

 

DTHERA SCIENCES

(Exact name of registrant as specified in its charter)

 

Nevada 90-0925768

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

7310 Miramar Rd., Suite 350, San Diego, CA 92126

(Address of principal executive offices)

 

Issuer’s telephone number: (858) 215-6360

Securities Registered pursuant to Section 12(b) of the Act: None

Securities Registered pursuant to Section 12(g) of the Exchange Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes o  No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.

Yes o  No x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes x  No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o Accelerated filer o
Non-accelerated filer o  (Do not check if a smaller reporting company) Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o  No x

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was $2,517,747 as of June 30, 2016, the last business day of the registrant’s most recently completed second fiscal quarter.

As of April 17, 2017, there were 43,069,401 shares of the registrant’s common stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

None

 

 

 
 

 

TABLE OF CONTENTS

 

PART I 1
ITEM 1. BUSINESS. 1
ITEM 1A. RISK FACTORS. 9
ITEM 1B. UNRESOLVED STAFF COMMENTS. 20
ITEM 2. PROPERTIES. 20
ITEM 3. LEGAL PROCEEDINGS. 20
ITEM 4. MINE SAFETY DISCLOSURES. 20
PART II 21
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. 21
ITEM 6. SELECTED FINANCIAL DATA. 21
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. 22
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. 24
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA. 24
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. 24
ITEM 9A. CONTROLS AND PROCEDURES. 25
ITEM 9B. OTHER INFORMATION 26
PART III 27
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. 27
ITEM 11. EXECUTIVE COMPENSATION. 28
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS. 30
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE. 31
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES. 31
PART IV 36
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES. 32
INDEX TO FINANCIAL STATEMENTS  

 

Throughout this report, unless otherwise designated, the terms “we,” “us,” “our,” “the Company” and “our company” refer to Dthera Sciences, a Nevada corporation. All amounts in this report are in U.S. Dollars, unless otherwise indicated.

 

EXPLANATORY NOTE

 

As reported by Dthera Sciences (formerly Knowledge Machine International, Inc.) (the “Company”) in a Current Report filed with the Commission on September 27, 2016, the Company closed a transaction whereby it acquired 100% of the outstanding stock of EveryStory, Inc., a Delaware corporation (“EveryStory”). The transaction is referred to in this Annual Report as the “EveryStory Transaction.”

 

On November 21, 2016, the Company filed an amendment to the prior current report to provide the financial statements of EveryStory as well as pro forma financial statements, all as required by the Commission’s rules. EveryStory’s year end is December 31, and the financial statements provided included the audited financial statements for the years ended December 31, 2015 and 2014, as well as reviewed interim financial statements through June 30, 2016.

 

As reported by the Company on a Current Report filed on November 17, 2016, the Company changed its fiscal year end from June 30 to December 31, to better track to the operations and business of the Company’s subsidiary, EveryStory, Inc., the operations of which have become the business and operations of the Company.

 

The Company is filing this Transition Report on Form 10-KT to provide the audited financial statements for the year ended December 31, 2016, following which time, the Company will report on a December 31 year-end basis.

 

 

 

  i  

 

 

FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 10-K contains “forward-looking statements,” as that term is defined under the Private Securities Litigation Reform Act of 1995. The use of words such as “anticipates,” “estimates,” “expects,” “intends,” “plans” and “believes,” among others, generally identify forward-looking statements. These forward-looking statements are based on our management's expectations and assumptions about future events as of the date of this Annual Report on Form 10-K, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. Forward-looking statements include statements about our expectations, beliefs or intentions regarding our product offerings, business, financial condition, results of operations, strategies or prospects. You can identify forward-looking statements by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These forward-looking statements are only predictions and reflect our views as of the date they are made with respect to future events and financial performance. We undertake no obligation to update, and we do not have a policy of updating or revising, these forward-looking statements.

 

PART I

 

ITEM 1. BUSINESS.

 

Historical Background

 

On September 21, 2016, the Company acquired a new operating subsidiary, EveryStory, Inc., a Delaware corporation (“ EveryStory ”). The Company is developing a Digital Therapeutic technology designed to deliver Reminiscence Therapy to certain patient populations, principally patients suffering from Alzheimer’s disease and dementia with the goal of a Quality of Life benefit and reduction in anxiety in those populations. Prior to the closing of the EveryStory transaction, the Company was incorporated in the State of Nevada on December 27, 2012, to engage in the development and operation of a business engaged in the distribution of high end edged tools produced outside the US. We conducted this business through October 22, 2014. On October 22, 2014, we acquired an operating subsidiary, Knowledge Machine, Inc., a Nevada corporation, (“ Knowledge Machine ”), which focused on new technologies, acquiring licensing rights to those technologies, and marketing the licensed technologies, and we sold off our edged tools business. In connection with the EveryStory transaction, we dissolved Knowledge Machine, and terminated the technology licensing and marketing operations.

 

Our principal offices are located at 7310 Miramar Road, Suite 350, San Diego, CA, 92126.

 

The Company qualifies as an “emerging growth company” as defined in the Jumpstart our Business Startups Act (the “ JOBS Act ”).

 

Acquisition of EveryStory and Change of Management

 

Entry into Amended and Restated Acquisition and Share Exchange Agreement; Completion of Acquisition of Assets

 

On September 21, 2016, we entered into an Amended and Restated Acquisition and Share Exchange Agreement (the “ A&R Agreement ”) with EveryStory and each of its shareholders (the “ Shareholders ”), and closed the acquisition (the “ Acquisition ”) of the ownership of EveryStory (the “ Closing ”). We had previously announced our entry into the original version of the A&R Agreement, and noted that the closing of the transaction was contingent on the completion of certain closing conditions.

 

The Company acquired all of the outstanding shares of EveryStory, and agreed to issue an aggregate of 77,377,713 pre-split /15,477,604 post-split shares of the Company’s common stock to the EveryStory holders, with the understanding that an additional 21,942,062 pre-split/4,388,997 post-split shares were issued to holders of EveryStory convertible debt instruments which are convertible or exercisable into shares of EveryStory common stock (collectively, the “ Exchange Shares ”). Additionally, prior to Closing, the parties agreed that certain shares of the Company’s common stock were to be returned to the Company for cancellation, resulting in the current Company’s shareholders owning an aggregate of 40,875,000 pre-split/8,000,000 post-split shares of the Company’s common stock immediately prior to the Closing.

 

 

 

  1  

 

 

Pursuant to the A&R Agreement, the 99,319,775 pre-split/ 19,866,601 post-split Exchange Shares issued or to be issued to the EveryStory constituted 75% of the total issued and outstanding shares of the Company’s common stock, and the legacy Company shareholders (who were the owners of the Company’s common stock immediately prior to the Closing) owned an aggregate of 40,875,000 shares, which constituted 25% of the total outstanding Company common stock.

 

The Company’s and EveryStory’s management agreed, and the A&R Agreement provides, that following the Closing, the Company will conduct a reverse stock split (discussed in more detail below), following which the outstanding shares of the Company’s Series A Preferred Stock will convert into a total of 8,000,000 post-reverse-split common stock. Following such conversion, the EveryStory owners will own or have the right to receive shares of the Company’s common stock equal to 55% of the then-outstanding Company common stock, and the Company legacy shareholders will own shares of the Company’s common stock equal to 45% of the then-outstanding Company common stock, consisting of 8,000,000 shares of Company common stock issued on conversion of the Company’s Series A Preferred Stock (22.5%) and 8,000,000 shares of the Company’s common stock owned by the other legacy Company shareholders (22.5%).

 

As a result of the Closing of the A&R Agreement, EveryStory became our wholly owned subsidiary. Additionally (as discussed more fully below), our directors and officers immediately prior to the Closing appointed the EveryStory management to become our new officers and directors, and then resigned from their positions with us. In addition, we terminated our pre-closing business operations and agreed to dissolve our other wholly owned subsidiary, Knowledge Machine.

 

There was no relationship between us and EveryStory or their principals or affiliates prior to the negotiation of the original agreement and the A&R Agreement.

 

Share Ownership Following Closing

 

Immediately prior to the Closing, there were 40,875,000 shares of the Company’s common stock. In connection with the Closing, the Company issued an aggregate of 77,377,713 pre-split/ 15,477,604 post-split shares to the EveryStory shareholders, and 21,942,062 pre-split/4,388,997 post-split shares were issued to the holders of EveryStory convertible debt instruments, and the parties to the A&R Agreement understand and anticipate that all such holders would exercise and convert their securities into the reserved shares of the Company.

 

On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. All share numbers provided in this Annual Report are given on a post-reverse-split basis.

 

Changes in Management

 

In connection with the Closing, Edward Cox, David Keene, and Larry Morgan were appointed as new members of our Board of Directors by the then-existing members of our Board of Directors, and Edward Cox was appointed as our Chief Executive Officer. Immediately following the appointment of Messrs. Cox, Keene, and Morgan to the Board and Mr. Cox as the Chief Executive Officer, Vivek R. Dave and Taylor Caswell resigned all positions as members of our Board of Directors and as officers.

 

The resignations were agreed to by the former directors in connection with the execution of the A&R Agreement and the closing of the Acquisition. There were no disagreements between us and any of the former directors.

 

Overview of Company

 

As previously disclosed, on September 21, 2016, Dthera Sciences (formerly Knowledge Machine International, Inc.) (the “Company”) (“ Dthera ”) acquired a new operating subsidiary, EveryStory, Inc., a Delaware corporation (“ EveryStory ”). The Company is developing a Digital Therapeutic technology designed to deliver Reminiscence Therapy to certain patient populations, principally patients suffering from Alzheimer’s disease and dementia with the goal of a Quality of Life benefit and reduction in anxiety in those populations. As of the date of this Report, EveryStory was our only subsidiary. Additional information relating to the business and operations of EveryStory, which has become our business and operations, is given below. In connection with the EveryStory transaction, the Company dissolved its other former subsidiary entity and terminated our prior business operations.

 

Our principal offices are located at 7310 Miramar Road, Suite 350, San Diego, CA, 92126, and the Company’s mailing address is 9921 Carmel Mountain Road, Suite 118, San Diego, CA 92129.

 

 

 

  2  

 

 

Organization and Structure

 

By way of background, EveryStory, Inc., a Delaware corporation, was founded on September 5, 2013. From inception until EveryStory formally launched operations in January 2014, EveryStory was a development stage company. Following the closing of the EveryStory transaction, EveryStory became a wholly owned subsidiary of Dthera Sciences (formerly Knowledge Machine International, Inc.), which divested itself of its former business and operations, and will focus on the business and operations of Digital Therapeutics and Reminiscence Therapy using the technology Platform going forward. References herein to “EveryStory” relate to the wholly owned Delaware corporation subsidiary. References to the “Company,” or “we,” “our,” or “us,” refer to the publicly reporting company, Dthera Sciences, formerly Knowledge Machine International, Inc., with the understanding that the Company will be implementing the business, operations, and plans of Dthera Sciences.

 

Overview – The Platform

 

Key components of the Platform include the ability to record audio narratives that are linked to specific photos and which can be played when the photos are viewed; the ability to import photos directly from computers or mobile devices; cloud-based data storage of the photos and the audio recordings; and multiple playback capabilities; collaborative creation and sharing of stories. The Platform was designed for mobile device platforms to enable users to record and store photos and audio easily and conveniently.

 

Application of the Platform – Digital Therapeutics and Reminiscence Therapy

 

Dthera’s management is focused on the goal of using the Company’s technology Platform, which streamlines the creation of personalized digital stories, to become the first clinically-proven Digital Therapeutic delivering Reminiscence Therapy to patients with Alzheimer's disease and Dementia. The Company already has a granted US patent (issued in 2010) that broadly covers the use of the Platform technology in Senior Living facilities. As of the date of this Report, Dthera had conducted a clinical trial with the University of California at San Diego (“ UCSD ”) with the goal of demonstrating that the EveryStory Platform is an effective anxiety reduction and quality of life therapy for those with Alzheimer’s disease or Dementia (“ ADOD ”). The results of the clinical trial were positive, as discussed in the summary abstract below:

 

This study examined the impact of a digital therapeutic software system on emotional functioning in a group of patients with Dementia. The digital therapeutic software is based on Reminiscence Therapy and allows the uploading of pictures and narration to create slideshow stories depicting important moments in the patient’s life. Patients were evaluated in their home and the initial evaluation consisted of patients responding to questionnaires assessing their level of depression, anxiety, overall level of emotional distress, and health related quality of life. Patients’ caregivers were also asked to rate the patient’s level of emotional functioning. After the initial assessment, patients and their caregivers were instructed on how to use the digital therapeutic software and created a slideshow. Patients then viewed the slideshow and immediately after were re-assessed using the same set of questionnaires as prior to the viewing. Results indicated that patients reported significantly less anxiety, depression, and overall emotional distress after having viewed their story. Furthermore, patient’s caregivers also reported that the patient appeared less emotionally distressed. The effect sizes for the significant results were typically large and ranged from 0.76 to 0.91 (effect sizes are used to quantify the magnitude of a statistical effect, with 0.50 typically being viewed as a moderate effect and 0.80 being considered a large effect of an intervention). These effect sizes, which were larger than anticipated, suggest that digital therapeutic software can have an immediate and positive impact on emotional functioning in patients with Dementia. In addition, the accessibility and ease of use of the software system suggests that this technology holds great promise for bringing important aspects of Reminiscence Therapy to patients with Dementia who are suffering from various mood symptoms.

 

In connection with this application of the Platform, Dthera is focusing on the developing fields of Digital Therapeutics and Reminiscence Therapy.

 

What is Digital Therapeutics?

 

The term “Digital Therapeutics” refers to using a digital system to treat a medical condition, much as one might use a drug, a human counselor, or surgery. Digital Therapeutics provide information and can be used alongside face-to-face physician consultancy. Many of these initiatives can be used to support treatment and as lifestyle tools to help manage health and well-being. As such, Digital Therapeutics technologies are used both as stand-alone and in combination with conventional therapies.

 

The goal of Digital Therapeutics is to mirror an effective treatment already in use, and then to use technology to scale it to a large patient population.

 

 

 

  3  

 

 

Dthera’s management believes that the EveryStory Platform is ideally positioned to be used as a Digital Therapeutics tool, and is focusing on using the Platform in the field of Reminiscence Therapy to work with patients with Alzheimer’s disease and dementia (“ADOD”).

 

What is Reminiscence Therapy?

 

Mosby’s Medical Dictionary defines Reminiscence Therapy as:

 

“A psychotherapeutic technique in which self-esteem and personal satisfaction are restored, particularly in older persons, by encouraging patients to review past experiences of a pleasant nature. It is used in Alzheimer's disease when initially long-term memory stores are more intact than short-term and in other forms of dementia.”

 

Reminiscence Therapy generally involves either discussing or reviewing recognizable memories from the past, which can help both calm and ground dementia patients when suffering from heightened anxiety.

 

Reminiscence Therapy involves the discussion of past activities, events and experiences with another person or group of people, usually with the aid of tangible prompts such as photographs, household and other familiar items from the past, music and archive sound recordings. Reminiscence Therapy groups may involve group meetings in which participants are encouraged to talk about past events at least once a week. Reminiscence Therapy may also involve individual sessions, in which the person is guided chronologically through life experiences, encouraged to evaluate them, and may produce a life story book. Family care-givers are increasingly involved in reminiscence therapy. Reminiscence Therapy is one of the most popular psychosocial interventions in dementia care, and is highly rated by staff and participants. There is evidence to suggest that Reminiscence Therapy also effective in improving mood in older people without dementia, however its effects on mood, cognition and well-being in dementia are less well understood. Studies have shown that Reminiscence Therapy can be an effective tool to help elderly patients and those suffering from depression and from dementia-related diseases, including Alzheimer’s disease to improve their well-being, self-esteem, and life satisfaction.

 

However, because Reminiscence Therapy is very labor intensive, requiring more professional or family caregivers to provide the therapy treatments, it is hard to scale to a large number of patients. Group therapy generally requires an increased number of care-givers or family members to provide a satisfactory experience which will provide the benefits from Reminiscence Therapy, which can be costly, both in terms of time and money.

 

Dthera’s management believes that one highly effective way to deliver Reminiscence Therapy to patients is through photos that bring back memories, and include voices that are familiar to them. Dthera’s management believes that the EveryStory Platform is uniquely positioned as a Digital Therapeutic that can provide Reminiscence Therapy to patients with Alzheimer’s disease and dementia (“ADOD”), in a manner that is scalable and cost-effective.

 

Multiple family members can create digital “stories” through the Platform, which are stored and can be accessed by the patient, either alone or with a caregiver. The Platform’s technology makes creating the stories easy, guiding the user with questions, asking for photos and related stories. The Platform then organizes the content, and prompts the creation of additional and related stories.

 

For example, a family member may be asked to upload a photo of the family home and to provide an audio story or memory about the home. The Platform will link the audio story to that photo, so that when the patient clicks on or touches the photo, the audio story will play automatically. The Platform also prompts the family member to include photos and stories from different categories, including vacations and travel, places the patient has lived, neighborhood friends, and other family members. Because the photos and stories are stored in the cloud, multiple family members can work together to create a library of stories that the patient can watch, listen to, and enjoy repeatedly.

 

Dthera’s engineers have made the Platform user-friendly, both on the content-creation side, and on the content-viewing side. The patient will be able to use an electronic tablet (such as an iPad), which will be tailored for that patient, and which will give the patient the opportunity to view photos and hear audio stories simply by touching the screen. The Platform can be set to play multiple photos and stories in a row. Family members and caregivers can help the patient to start viewing, but can attend to other duties while the patient watches and listens.

 

Scale of the Markets (US)

 

Dthera’s management believes that the potential market for the Digital Therapeutic and Reminiscence Therapy uses for the Platform are significant, and will continue to grow for the foreseeable future.

 

 

 

  4  

 

 

Highlights of the market opportunities include:

 

  · The 70+ population in the US is expected to grow faster than any other age group—from 28 million in 2010 to 53 million by 2030

 

  · Alzheimer's and other dementias (ADOD)

 

  o For 2016, total payments for health care, long-term care and hospice are estimated to be $236 billion.

 

  · Senior Living and Long Term Care

 

  o The National Investment Center for the Seniors Housing & Care Industry (“ NIC ”) estimates expenditures for “long-term care services” between $210 and $306 billion

 

Annual Costs of Senior Living Care (US)

 

Costs required for the care ADOD patients are as much five times (average $77,381 per year) vs. someone of the same age without dementia ($15,550 per year)

 

 

 

 

 

  5  

 

 

 

 

Business Model

 

Dthera intends to offer the Digital Therapeutics technology directly to the families of ADOD patients as a clinical supported therapy. Additionally, Dthera intends to partner directly with Senior Living management firms, to introduce to the resident and the resident’s families starting in the second or third quarters of 2017, with initial revenues anticipated 30-60 days after introduction.

 

In both the direct-to-Patient and the Senior Living-management models, management anticipates that the product, which will include a digital tablet in the patient’s room, with monthly and/or yearly rates for participation in the program.

 

Additionally, Dthera intends to seek partners in international markets to help make introductions to the Senior Living-type markets and other implementation techniques.

 

Once Dthera has begun implementation of the Digital Therapeutics and Reminiscence Therapy applications of the Platform, Dthera’s management intends to further explore other applications of the Platform targeting other indications with patients that could benefit from the core technology,.

 

Intellectual Property

 

As noted above, Dthera has acquired an issued patent from Seniors in Touch, Patent Number US 7721946 B2 (the “ ES Patent ”) on its technology. The title of the ES Patent is “EveryStory Senior Living Patent,” and is summarized as follows: “ A system and method is disclosed whereby a patient at a senior care facility can send and receive messages via the internet. Tools are provided to manage the patients, the patient's relative contact, mail, and photo collection. Relatives can be designated to suggest changes to the contacts and edit the contents of the patient's contacts files. The messages may be audio, video or text and the user friendly system helps the patients navigate through the process. Notification is provided so that the relatives and patients know when a message had been received. Further notification is provided if a prolonged period lapses after receipt of a message to a patient and the message has not been read. ” The ES Patent was filed on February 21, 2007, and the publication date was May 25, 2010.

 

In summary, Dthera has the following intellectual property:

 

U.S. Patent No. 7,721,946 – SENIOR CITIZEN COMMUNICATION SYSTEM
U.S. Patent Publication No. 2016/0267081 – STORY CAPTURE SYSTEM
PCT Publication No. WO 2016/145408 – STORY CAPTURE SYSTEM
U.S. Application (Unpublished) - THERAPEUTIC USES OF DIGITAL STORY CAPTURE SYSTEMS

 

 

 

  6  

 

 

Operations

 

Substantially all of Dthera’s communications, network and the computer hardware used to operate our websites are co-located in a third-party facility. In addition, we use a combination of third-party, Internet-based or cloud computing services and off-site backup services in connection with our business operations and our disaster recovery systems. We have designed our websites to be highly available, secure and cost-effective using a variety of proprietary software, third-party services and freely available and commercially supported tools. We can scale to accommodate increasing numbers of registered users by adding relatively inexpensive industry-standard software. We use encryption technologies and certificates for secure transmission of personal information between users and our websites.

 

Competition

 

Although Digital Therapeutics is a relatively new space, Dthera faces indirect competition from companies in the mobile health, photo archiving, photo/audio interconnectivity, social networking and cloud storage sectors. Many of these companies are considerably larger, have greater resources and a longer operating history than does EveryStory. Management believes, however, that this is indirect competition because, to the best of management’s knowledge, there is not a competitor product that has the storytelling capability of the EveryStory platform. Management expects that competition in the sector will grow and become more intense through industry consolidation as well as the emergence of new participants in EveryStory’s market. EveryStory intends to compete on the basis of ease of use, technology, brand recognition, quality of products and service and support. Our competitive strategy may be significantly affected in the future by many external factors. Among them are marketing costs, technology and our current and future competitors’ pricing and marketing strategies.

 

As we build and develop the digital therapeutics applications of the Platform, we will continue to review and disclose information relating to competition in the digital therapeutic markets.

 

Recent Developments

 

Reverse Stock Split; Conversion of Outstanding Knowledge Machine Series A Preferred Stock

 

On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. In lieu of issuing fractional shares, the Company’s transfer agent was instructed to round up to the nearest whole share.

 

Immediately following the effectiveness of the A&R Agreement, the Company’s 47,500 outstanding shares of Series A Preferred Stock were converted, pursuant to their terms, into 8,000,000 shares of post-reverse split common stock. Additionally, through the application of the reverse split, the 40,875,000 shares of common stock held by the legacy shareholders of Knowledge Machine following the closing of the EveryStory Transaction and immediately prior to the reverse split became 8,000,000 shares of common stock. Accordingly, the legacy shareholders of Knowledge Machine International, including the holders of the shares of Series A Preferred Stock, owned an aggregate of 16,000,000 shares of the Company’s common stock. The shares of the Company’s common stock held by the former EveryStory Shareholders went from 77,377,713 to 15,477,604 shares by virtue of the reverse split, with additional shares of the Company’s common stock issued to the holders of EveryStory convertible instruments, including convertible notes and other derivative securities.

 

Following the reverse split, the Company had 35,866,601 shares of common stock outstanding.

 

The Reverse Split was approved by the Board of Directors and the shareholders of the Company prior to the closing of the EveryStory Transaction, which approval was included in the closing conditions to the EveryStory Transaction.

 

Name Change; Ticker Symbol Change

 

In connection with the closing of the EveryStory Transaction and the divestiture of the prior business and operations of the Company, as well as the new focus of the Company on the digital therapeutics and reminiscence therapy focus of the Company, the Board of Directors and the majority shareholders of the Company immediately following the closing of the EveryStory Transaction approved an amendment to the Company’s Articles of Incorporation to change the name of the Company (the “Name Change”) from Knowledge Machine International, Inc., to Dthera Sciences . The Name Change took effect at the same time as the reverse split on November 2, 2016.

 

 

 

  7  

 

 

In connection with the name change, and to help current shareholders and new investors better understand the business of the Company, the Company requested that a new ticker symbol be assigned to the Company. The Company was assigned “ DTHR ” as the new ticker symbol.

 

New Website

 

Additionally, the Company launched a new website, www.dthera.com, to provide information about the Company, its business and operations, and additional information about digital therapeutics and reminiscence therapy. The link provided is for informational purposes only, and no information contained on the Company’s website should be deemed to be part of this or any filing of the Company.

 

Change in Auditors

 

On November 8, 2016, the Company notified Pritchett Siler & Hardy, P.C. (“PSH”), an independent registered public accounting firm, that effective as of November 8, 2016, the Company had decided to dismiss PSH as the Company’s independent registered public accounting firm. The decision to dismiss PSH was made and approved by the Company’s Board of Directors.

 

The audit reports of PSH on the Company's financial statements for the fiscal years ended June 30, 2016 and 2015, did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to audit scope, or accounting principles, except that the PSH reports for these fiscal years ended contained a going concern uncertainty. This uncertainty expressed substantial doubt about the Company's ability to continue as a going concern based on working capital deficits and the lack of profitable operations.

 

During the two most recent fiscal years and through November 8, 2016, the Company had no disagreements with PSH on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement, if not resolved to their satisfaction, would have caused PSH to make reference to the subject matter of the disagreement in connection with its reports. In addition, during that time there were no reportable events (as defined in Item 304(a)(1)(v) of Regulation S-K).

 

Effective as of November 8, 2016, the Company engaged Sadler, Gibb & Associates, LLC (“Sadler Gibb”) as its new independent registered public accounting firm. The decision to engage Sadler Gibb was made and approved by the Company's Board of Directors. The headquarters office of Sadler Gibb is located in Salt Lake City, Utah, and Sadler Gibb is registered with the Public Company Accounting Oversight Board.

 

During the two most recent fiscal years and through November 8, 2016, the Company has not consulted with Sadler Gibb regarding either: (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements or (ii) any matter that was either subject of a disagreement (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K) or a reportable event (as that term is described in Item 304(a)(1)(v) of Regulation S-K).

 

Change in Fiscal Year End

 

On November 12, 2016, the Company’s Board of Directors approved a change in fiscal year-end of the Company from a June 30 year-end to a calendar year-end of December 31. The Board of Directors’ decision to change the fiscal year-end is intended to assist the financial community in its analysis of the business and in comparing Dthera’s financial results to others in the industry, and to synchronize the Company's fiscal reporting period with the Securities and Exchange Commission's required year-end reserve reporting period of December 31.

 

Additionally, the Company’s principal operating subsidiary, EveryStory, Inc., has a December 31 year end, and because the Company’s principal operations are focused on the implementation of the EveryStory Platform, and because EveryStory’s financial statements are prepared on a calendar year end basis, the Board of Directors determined it to be in the best interests of the Company to not have to re-audit the EveryStory financial statements to reflect a June 30 year end. As such, the Board of Directors approved the change.

 

Closing of Private Offering

 

On April 10, 2017, the Company closed a private placement offering (the “Private Offering”) in which the Company raised gross proceeds of approximately $1,233,900 The Company sold an aggregate of 7,119,500 shares of its common stock in the Private Offering. The Company’s management intends to use the proceeds to repay certain convertible debt instruments and to use the proceeds for general corporate purposes and working capital.

 

 

 

  8  

 

 

Results of Clinical Trial

 

On April 10, 2017, the Company announced the conclusion of a clinical study conducted at University of California San Diego School of Medicine, which demonstrated positive results of its product, ReminX on patients with Alzheimer's disease and Dementia. The study was conducted by J. Vincent Filoteo, PhD, Professor of Psychiatry and Neuropsychology Section Chief in the Department of Psychiatry at UC San Diego School of Medicine.

 

In the study, subjects were shown personalized video slideshow stories, which were created by the Platform itself, displaying moments from various points in their life along with narration provided by family members.

 

The underlying science behind the product is called “Reminiscence Therapy” (“RT”), which is a well-known and well-understood cognitive behavioral therapy, primarily used with the elderly, to both reduce anxiety and increase the quality of life in patients with dementia or those experiencing isolation. RT is usually provided either in a one-on-one setting or in groups. One of the key limitations to RT in the past was that it is very labor intensive, typically involving a family member or caregiver sitting with the patient manually going through the stories, therefore rendering it not easily scalable.

 

The Platform enables an immediate implementation of the core features of RT that can be provided to patients at any time. Dthera’s Platform allows for the key elements of the therapy to be delivered through a Digital Therapeutic software. Driven by a proprietary artificial intelligence engine, Dthera's software helps families populate stories so that patients in long term care facilities have constant access to personalized Reminiscence Therapy.

 

Dr. Filoteo stated: “The results of this proof-of-concept study are very promising and have the potential to help herald a new way to deliver a form of relief to patients suffering with dementia and related anxiety or depression. Our results indicate that the use of this software led to an immediate and significant decrease in anxiety and depression in our patients, which was also observed by their caregivers. These significant results, which were larger in magnitude than expected, form the basis to further investigate the neuropsychiatric mechanisms that underlie improved mood through the use of this software technology.”

 

Dthera’s management believes that digital therapeutics – the use of software to create a medical effect in patients – is an exciting new frontier for medicine, and that this clinical study supports that the ReminX Platform can be used to scale out otherwise labor-intensive medical practices.

 

Employees

 

As of the date of the Report, the Company had one full-time employee, our Chief Executive Officer, and no part-time employees. Other than the CEO, all others working with the Company are consultants, working with the Company under consulting agreements. Management believes that our relationship with these consultants is good.

 

ITEM 1A. RISK FACTORS.

 

An investment in our Company involves significant risks, including the risks described below. You should consult with your own financial and legal advisors and carefully consider the material risks described below, together with all of the other information in this Annual Report on Form 10-K. If any of the following risks actually occur, our business, financial condition and results of operations could suffer, and the trading price of our common stock could decline.

 

Risks Related to Our Company and Its Business

 

We have a limited operating history and limited historical financial information upon which you may evaluate our performance.

 

You should consider, among other factors, our prospects for success in light of the risks and uncertainties encountered by companies that, like us, are in their early stages of development. We may not successfully address the usual and ordinary risks and uncertainties associated with being an early stage company or successfully implement our existing and new products and services. If we fail to do so, it could materially harm our business. Even if we accomplish these objectives, we may not generate the positive cash flows or profits we anticipate in the future. Unanticipated problems, expenses and delays are frequently encountered in establishing a new business and developing new products and services. These include, but are not limited to, inadequate funding, lack of consumer acceptance, competition, product development, and inadequate sales and marketing. Our failure to meet any of these conditions would have a material adverse effect upon us and may force us to reduce or curtail our operations. No assurance can be given that we will operate profitably. Even though we are being managed by individuals with significant industry experience, our limited operating history makes it difficult to predict the long-term success of our business model.

 

 

 

  9  

 

 

We depend on key personnel.

 

For the foreseeable future, our success will depend largely on management’s industry knowledge, marketing skills and relationships with key investors, customer bases, and industry leaders. Many key contributors working with the Company are outside consultants providing services to the Company in their areas of expertise. Should any of these individuals leave Dthera or cease to provide consulting services, such departures may have a material adverse effect on our future results of operations.

 

We will indemnify Management and the members of the Board of Directors.

 

These key decision-makers will be entitled to indemnification from Dthera except in certain circumstances, as more fully set forth in our Articles of Incorporation and Bylaws, each as amended or amended and restated.

 

If we fail to effectively manage growth, our business, brand and reputation, results of operations, and financial condition may be adversely affected.

 

We may experience a rapid growth in operations, which may place significant demands on our management team and our operational and financial infrastructure. As we continue to grow, we must effectively identify, integrate, develop and motivate new employees, and maintain the beneficial aspects of our corporate culture. To attract top talent, we believe we will have to offer attractive compensation packages. The risks of over-hiring or over-compensating and the challenges of integrating a rapidly growing employee base may impact profitability. Additionally, if we do not effectively manage our growth, the quality of our services could suffer, which could adversely affect our business, brand and reputation, results of operations and financial condition. If operational, technology and infrastructure improvements are not implemented successfully, our ability to manage our growth will be impaired and we may have to make significant additional expenditures to address these issues. To effectively manage our growth, we will need to continue to improve our operational, financial and management controls and our reporting systems and procedures. This will require that we refine our information technology systems to maintain effective online services and enhance information and communication systems to ensure that our employees effectively communicate with each other and our growing base of customers. These system enhancements and improvements will require significant incremental and ongoing capital expenditures and allocation of valuable management and employee resources. If we fail to implement these improvements and maintenance programs effectively, our ability to manage our expected growth and comply with the rules and regulations that are applicable to publicly reporting companies will be impaired and we may incur additional expenses.

 

As we enter the digital health and therapy market, our business may be subject to government regulation, and will be impacted by economic and business conditions, which may have a negative impact on our ability to develop and implement our business strategy, and our ability to continue operations.

 

The digital healthcare business may be impacted by economic volatility, consumer spending patterns and market share gains of competitors’ branded products. Additionally, the digital healthcare market is largely new and untested; the uptake of products may not meet uptake projections as there is little to no prior data. Although digital healthcare products exist, they are mostly focused on helping or focusing on aspects such as diet, smoking cessation, and medication management. The categorization of our Platform as a participant in the digital healthcare space will require successful research studies. In addition, the US Health Industry is highly regulated and subject to frequent and substantial changes. The impacts of these regulations and the general market conditions could have a negative impact on our business and operations.

 

If our efforts to retain and attract subscribers are not successful, our revenues may be materially affected.

 

We intend to generate substantially all of our revenues from subscriptions to our services. We must continue to retain existing and attract new subscribers, which we seek to do in part by investing in our product platform and new services and technologies. If our efforts to satisfy our existing subscribers are not successful, we may not be able to retain them, and, as a result, our revenues would be adversely affected. For example, if consumers do not perceive our services to be reliable, valuable and of high quality, if we fail to regularly introduce new and improved services and more content, or if we introduce new services that are not favorably received by the market, we may not be able to retain existing or attract new subscribers. We rely on our marketing and advertising efforts to attract new subscribers. If we are unable to effectively retain existing subscribers and attract new subscribers, our business, financial condition and results of operations would be materially adversely affected.

 

 

 

  10  

 

 

If we experience excessive rates of subscriber cancellation, our revenues and business may be harmed.

 

We must continually add new subscribers both to replace subscribers who choose to cancel their subscriptions and to grow our business beyond our current subscriber base. Subscribers may choose to cancel their subscriptions for many reasons, including a desire to reduce discretionary spending, a perception that they do not have sufficient time to use the service or otherwise do not use the service sufficiently, the service is a poor value, competitive services provide a better value or experience or subscriber service issues are not satisfactorily resolved. Subscribers may choose to cancel their subscriptions at any time prior to the renewal date. We may also experience fluctuations in cancellations as we pursue new subscribers through new marketing channels or if we have a large number of subscriptions come up for renewal in the same period.

 

If our subscriber cancellations increase, we would be required to increase the rate at which we add new subscribers in order to maintain and grow our revenues. If excessive numbers of subscribers cancel our service, we may be required to incur significantly higher marketing and advertising expenses than we currently anticipate to replace these subscribers with new subscribers. If we are unable to attract new subscribers in numbers greater than the impact of our cancellations, our subscriber base will decrease and our business, financial condition and results of operations may be materially adversely affected.

 

Our business depends substantially on customers renewing their subscriptions with us and expanding their use of our services. Any decline in our customer renewals or failure to convince our customers to broaden their use of our services would harm our future operating results.

 

In order for us to maintain or improve our operating results, it is important that our customers renew their subscriptions with us when the existing subscription term expires. Our customers have no obligation to renew their subscriptions upon expiration, and we cannot assure you that customers will renew subscriptions at the same or higher level of service, if at all.

 

Our retention rate may decline or fluctuate as a result of a number of factors, including our customers’ satisfaction or dissatisfaction with our services, the effectiveness of our customer support services, our pricing, the prices of competing products or services, the effects of global economic conditions or reductions in our customers’ spending levels. If our customers do not renew their subscriptions or renew on less favorable terms, our revenue may decline, and we may not realize improved operating results from our customer base.

 

A change in our mix of subscription durations could have a significant impact on our revenues, net subscribers and revenue visibility.

 

We intend periodically to evaluate and test the types of subscriptions that we offer. Based on the results of any product or price testing conducted, we may change the types of subscriptions we offer or we may price and market different types of subscriptions. If a higher percentage of our subscribers choose a shorter subscription duration, we would likely experience higher cancellation volumes, which may result in decreased immediate and long-term revenues. In the future, we may continue to perform product and price tests involving our prospective users, the results of which could affect our number or mix of subscribers and may have a material adverse impact on our results of operations, and key operating metrics.

 

We cannot accurately predict new subscription rates and the impact these rates may have on our future revenue and operating results.

 

In order for us to improve our operating results and continue to grow our business, it is important that we continue to attract new customers. To the extent we are successful in increasing our customer base, we could incur increased losses because costs associated with new customers are generally incurred up front, while revenue is recognized ratably over the term of our subscription services. Alternatively, to the extent we are unsuccessful in increasing our customer base, we could also incur increased losses as costs associated with marketing programs and new products intended to attract new customers would not be offset by incremental revenue and cash flow. All of these factors can negatively impact our future revenue and operating results.

 

 

 

  11  

 

 

If our marketing and advertising efforts fail to generate additional revenues on a cost-effective basis, or if we are unable to manage our marketing and advertising expenses, it could materially harm our results of operations and growth.

 

Our future growth and profitability, as well as the maintenance and enhancement of our brands, will depend in large part on the effectiveness and efficiency of our marketing and advertising expenditures. We intend to use a diverse mix of marketing and advertising programs to promote our products and services, and we plan periodically to adjust our mix of these programs. Significant increases in the pricing of one or more of our marketing and advertising channels could increase our marketing and advertising expense or cause us to choose less effective marketing and advertising channels. Further, we may over time become disproportionately reliant on one channel or partner, which could increase our operating expenses. Because we recognize revenues ratably over the subscription period, we have incurred and may in the future incur marketing and advertising expenses significantly in advance of the time we anticipate recognizing revenues associated with such expenses, and our marketing and advertising expenditures may not continue to result in increased revenues or generate sufficient levels of brand awareness. If we are unable to maintain our marketing and advertising channels on cost-effective terms or replace existing marketing and advertising channels with similarly effective channels, our marketing and advertising expenses could increase substantially, our subscriber levels could be affected adversely, and our business, financial condition and results of operations may suffer. In addition, our expanded marketing efforts may increase our subscriber acquisition cost, as additional expenses may not result in sufficient customer growth to offset cost, which would have an adverse effect on our business, financial condition and results of operations.

 

Any significant disruption in service on our Web site or in our computer systems, which are currently hosted primarily by a single third-party, could damage our reputation and result in a loss of subscribers, which would harm our business and operating results.

 

Subscribers access our service through our Web site and through mobile device apps. Our brand, reputation and ability to attract, retain and serve our subscribers depend upon the reliable performance of our Web site, network infrastructure, content delivery processes and payment systems. Interruptions in these systems, whether due to system failures, computer viruses or physical or electronic break-ins, could affect the security or availability of our Web site and prevent our subscribers from accessing our data and using our products and services. Problems with the reliability or security of our systems may harm our reputation and require disclosure to our lenders, and the cost of remedying these problems could negatively affect our business, financial condition and results of operations.

 

Substantially all of our communications, network and computer hardware used to operate our Web site are located in facilities owned and operated by a third party. We do not own or control the operation of these facilities. Our systems and operations are vulnerable to damage or interruption from fire, flood, power loss, telecommunications failure, terrorist attacks, acts of war, electronic and physical break-ins, computer viruses, earthquakes and similar events. The occurrence of any of the foregoing events could result in damage to our systems and hardware or could cause them to fail completely, and our insurance may not cover such events or may be insufficient to compensate us for losses that may occur. Our systems are not completely redundant, so a failure of our system at our primary site could result in reduced functionality for our customers, and a total failure of our systems at both sites could cause our Web site to be inaccessible by our customers. Problems faced by our third-party Web hosting provider, with the telecommunications network providers with whom it contracts or with the systems by which it allocates capacity among its customers, including us, could adversely affect the experience of our subscribers. Our third-party Web hosting provider could decide to close its facilities without adequate notice. In addition, any financial difficulties, such as bankruptcy reorganization, faced by our third-party Web hosting provider or any of the service providers with whom it contracts may have negative effects on our business, the nature and extent of which are difficult to predict. Additionally, if our third-party Web hosting provider is unable to keep up with our growing needs for capacity, this could have a material adverse effect on our business. Any errors, defects, disruptions or other performance problems with our services could harm our reputation and have an adverse effect on our business, financial condition and results of operations.

 

Our possession and use of personal information present risks and expenses that could harm our business. Unauthorized disclosure or use of such data, whether through breach of our network security or otherwise, could expose us to significant liability and damage our reputation.

 

Maintaining the security of our information technology and network systems infrastructure is of critical importance because we handle confidential subscriber, registered user, employee and other sensitive data, such as names, addresses, credit card numbers and other personal information. In addition, our online systems include the content that our registered users upload onto our Web sites, such as family records and photos. This content is often personally meaningful, and our registered users may rely on our online system to store digital copies of such content. If we were to lose such content, if our users’ private content were to become publicly available or if third parties were able to gain unauthorized access to such content, we may face liability and harm to our brand and reputation.

 

 

 

  12  

 

 

We anticipate that most of our subscribers will use credit and debit cards to purchase our products and services. If we or our processing vendors were to have problems with our billing software, it could have an adverse effect on our subscriber satisfaction and could cause one or more of the major credit card companies to disallow our continued use of their payment services. In addition, if our billing software fails to work properly and, as a result, we do not charge our subscribers’ credit cards on a timely basis or at all, our business, financial condition, cash flows and results of operations could be materially affected.

 

We and our vendors use commercially available encryption technology to transmit personal information when taking orders. We use security and business controls to limit access and use of personal information, including registered users’ uploaded content. However, third parties may be able to circumvent these security and business measures including by developing and deploying viruses, worms and other malicious software programs that are designed to attack or attempt to infiltrate our systems and networks. In addition, employee error, malfeasance or other errors in the storage, use or transmission of personal information could result in a breach of registered user or employee privacy.

 

Additionally, we may not be able to prevent security breaches involving customer transaction data. If we experience a security breach or other lapse in the handling of confidential information of this kind, the incident could give rise to risks including data loss, litigation and liability, and could harm our reputation or disrupt our operations, any of which could materially adversely affect our business. In addition, various states and countries have differing laws regarding protection of customer privacy and confidential information, including notification requirements in the event of certain breaches or losses of information. Efforts to comply with these laws and regulations increase our costs of doing business and failure to achieve compliance could result in substantial liability to our business and harm our reputation. In the event of a security breach or loss of confidential information, we could be subject to fines, penalties, damages and other remedies under applicable laws, any of which could have a material adverse impact on our reputation, business, operating results and financial condition.

 

If third parties improperly obtain and use the personal information of our registered users or employees, we may be required to expend significant resources in efforts to address these problems. A major breach of our network security and systems could have serious negative consequences for our businesses, including possible fines, penalties and damages, reduced demand for our products and services, an unwillingness of subscribers to provide us with their credit card or payment information, an unwillingness of registered users to upload family records or photos onto our Web sites, harm to our reputation and brand and loss of our ability to accept and process subscriber credit card orders. Similarly, if a well-publicized breach of data security at any other major consumer Web site were to occur, there could be a general public loss of confidence in the use of the Internet for commercial transactions. Any of these events could have material adverse effects on our business, financial condition and results of operations. In addition, we may have inadequate insurance coverage to compensate for any related losses.

 

We do not expect to be profitable for the foreseeable future.

 

We will have losses and accumulated deficit as a result of the substantial investments we will make to acquire new customers and develop our services. We intend to continue scaling our business to increase our number of users and to meet the increasingly complex needs of our customers. We expect to invest and to continue to invest, in our sales and marketing organizations to sell our services around the world and in our development organization to deliver additional features and capabilities of our cloud services to address our customers’ evolving needs. We also expect to continue to make significant investments in our datacenter infrastructure and in our professional service organization as we focus on customer success. As a result of our continuing investments to scale our business in each of these areas, we do not expect to be profitable for the foreseeable future. Furthermore, to the extent we are successful in increasing our customer base, we will also incur increased losses due to upfront costs associated with acquiring new customers, particularly as a result of the limited free trial version of our service, and the nature of subscription revenue which is generally recognized ratably over the term of the subscription period. We cannot assure you that we will achieve profitability in the future or that, if we do become profitable, we will sustain profitability.

 

If we are not able to provide successful enhancements, new features and modifications to our services, our business could be adversely affected.

 

Our industry is marked by rapid technological developments and new and enhanced applications and services. If we are unable to provide enhancements and new features for our existing services or new services that achieve market acceptance or that keep pace with rapid technological developments, our business could be adversely affected. The success of enhancements, new features and services depends on several factors, including the timely completion, introduction and market acceptance of such enhancements, features or services. Failure in this regard may significantly impair our revenue growth. In addition, because our services are designed to operate on a variety of systems, we will need to continuously modify and enhance our services to keep pace with changes in internet-related hardware, mobile operating systems such as iOS and Android, and other software, communication, browser and database technologies. We may not be successful in either developing these modifications and enhancements or in bringing them to market in a timely fashion. Furthermore, modifications to existing platforms or technologies will increase our research and development expenses. Any failure of our services to operate effectively with future network platforms and technologies could reduce the demand for our services, result in customer dissatisfaction and adversely affect our business.

 

 

 

  13  

 

 

Our platform must integrate with a variety of operating systems and software applications that are developed by others, and if we are unable to ensure that our solutions interoperate with such systems and applications, our service may become less competitive, and our operating results may be harmed.

 

We offer our services across a variety of operating systems and through the internet. We are dependent on the interoperability of our platform with third-party mobile devices, desktop and mobile operating systems, as well as web browsers that we do not control. Any changes in such systems, devices or web browsers that degrade the functionality of our services or give preferential treatment to competitive services could adversely affect usage of our services. In order to deliver high quality services, it is important that they work well with a range of operating systems, networks, devices, web browsers and standards that we do not control. In addition, because a substantial number of our users access our services through mobile devices, we are particularly dependent on the interoperability of our services with mobile devices and operating systems. We may not be successful in developing relationships with key participants in the mobile industry or in developing services that operate effectively with these operating systems, networks, devices, web browsers and standards. In the event that it is difficult for our users to access and use our services, our user growth may be harmed, and our business and operating results could be adversely affected.

 

Our business depends on continued and unimpeded access to the Internet by us and our members on personal computers and mobile devices. If government regulations relating to the Internet or other areas of our business change, if Internet access providers are able to block, degrade, or charge for access to certain of our products and services, or if third parties disrupt access to the Internet, we could incur additional expenses and the loss of members and customers.

 

Our products and services depend on the ability of our members and customers to access the Internet through their personal computers and mobile devices. Currently, this access is provided by companies that have significant market power in the broadband and Internet access marketplace, including incumbent telephone companies, cable companies, mobile communications companies, and government-owned service providers, any of whom could take actions that degrade, disrupt, or increase the cost of user access to our products or solutions, which would, in turn, negatively impact our business. In addition, Internet access could be disrupted by other third parties. Further, the adoption of any laws or regulations that adversely affect the growth, popularity or use of the Internet, including laws limiting Internet neutrality, could decrease the demand for our subscription service or the usage of our services and increase our cost of doing business.

 

One of our marketing strategies is to offer a limited free version of our service, and we may not be able to realize the benefits of this strategy.

 

We offer a limited version of our service to users free of charge in order to promote additional usage, brand and product awareness, and adoption. Some users never convert from a free version to a paid version of our service. Our marketing strategy also depends in part on persuading users who use the free version of our service to convince others to purchase and use our service. To the extent that these users do not become, or lead others to become, paying customers, we will not realize the intended benefits of this marketing strategy, and our ability to grow our business and revenue may be harmed.

 

Any failure to protect our intellectual property rights could impair our ability to protect our proprietary technology and our brand.

 

Our success and ability to compete depend in part on our intellectual property. As of January 30, 2017, Dthera had one patent issued in the U.S,; one patent pending application in the U.S.; one international patent filed; and an unpublished patent application, all relating to the Company’s core technology of reminiscence therapy technologies. As Dthera continues to develop its intellectual property, it will file additional patent applications as appropriate. We primarily rely on copyright, trade secret and trademark laws, trade secret protection and confidentiality or license agreements with our employees, customers, partners and others to protect our intellectual property rights. However, the steps we take to protect our intellectual property rights may be inadequate. Our pending applications may not result in the issuance of patents. If we file patent applications outside the U.S., we may have to expend significant resources to obtain additional patents as we expand our international operations.

 

In order to protect our intellectual property rights, we may be required to spend significant resources to monitor and protect these rights. Litigation brought to protect and enforce our intellectual property rights could be costly, time-consuming and distracting to management and could result in the impairment or loss of portions of our intellectual property. Furthermore, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims and countersuits attacking the validity and enforceability of our intellectual property rights. Accordingly, we may not be able to prevent third parties from infringing upon or misappropriating our intellectual property. Our failure to secure, protect and enforce our intellectual property rights could materially adversely affect our brand and adversely impact our business.

 

 

 

  14  

 

 

We rely on third parties for certain financial and operational services essential to our ability to manage our business. A failure or disruption in these services could materially and adversely affect our ability to manage our business effectively.

 

We rely on third parties for certain essential financial and operational services. Traditionally, the vast majority of these services have been provided by large enterprise software vendors who license their software to customers. However, we receive many of these services on a subscription basis from various software-as-a-service companies that are smaller and have shorter operating histories than traditional software vendors. Moreover, these vendors provide their services to us via a cloud-based model instead of software that is installed on our premises. As a result, we depend upon these vendors providing us with services that are always available and are free of errors or defects that could cause disruptions in our business processes, which would adversely affect our ability to operate and manage our operations.

 

We focus on product innovation and user engagement rather than short-term operating results.

 

We focus on developing and launching new and innovative products and features, as well as on improving the user experience for our services. We also focus on growing the number of Dthera users and paying organizations through indirect channel sales and through word-of-mouth by individual users, some of whom use our services at no cost. We prioritize innovation and the experience for users on our platform, as well as the growth of our user base, over short-term operating results. We make product and service decisions that may reduce our short-term operating results if we believe that the decisions are consistent with our goals to improve the user experience and to develop innovative features that we feel our users desire. These decisions may not be consistent with the short-term expectations of investors and may not produce the long-term benefits that we expect.

 

We plan to provide service level commitments under our subscription agreements. If we fail to meet these contractual commitments, we could be obligated to provide credits or refunds for prepaid amounts related to unused subscription services or face subscription terminations, which could adversely affect our revenue. Furthermore, any failure in our delivery of high-quality customer support services may adversely affect our relationships with our customers and our financial results.

 

We anticipate that our subscription agreements with customers will provide certain service level commitments. If we are unable to meet these stated service level commitments or suffer periods of downtime that exceed the periods allowed under our customer agreements, we may be obligated to provide these customers with service credits which could significantly impact our revenue in the period in which the downtime occurs and the credits could be due. We could also face subscription terminations, which could significantly impact both our current and future revenue. Any extended service outages could also adversely affect our reputation, which would also impact our future revenue and operating results.

 

Our customers depend on our customer success organization to resolve technical issues relating to our services. We may be unable to respond quickly enough to accommodate short-term increases in customer demand for support services. Increased customer demand for these services, without corresponding revenue, could increase costs and adversely affect our operating results. In addition, our sales process is highly dependent on the ease of use of our services, on our reputation and on positive recommendations from our existing customers. Any failure to maintain high-quality customer support, or a market perception that we do not maintain high-quality support, could adversely affect our reputation and our ability to sell our services to existing and prospective customers.

 

Our services contain open source software, whose licenses may pose particular risks to our proprietary software, products, and services in a manner that could have a negative impact on our business.

 

We use open source software in our services and will use open source software in the future. Additionally, we may from time to time face claims from third parties claiming ownership of, or demanding release of, the open source software or derivative works that we developed using such software, which could include our proprietary source code, or otherwise seeking to enforce the terms of the applicable open source license. These claims could result in litigation and could require us to make our software source code freely available, purchase a costly license or cease offering the implicated services unless and until we can re-engineer them to avoid infringement. This re-engineering process could require significant additional research and development resources, and we may not be able to complete it successfully. In addition to risks related to license requirements, use of certain open source software can lead to greater risks than use of third-party commercial software, as open source licensors generally do not provide warranties or controls on the origin of software. Additionally, because any software source code we contribute to open source projects is publicly available, our ability to protect our intellectual property rights with respect to such software source code may be limited or lost entirely, and we are unable to prevent our competitors or others from using such contributed software source code. Any of these risks could be difficult to eliminate or manage, and, if not addressed, could have a negative effect on our business, financial condition and operating results.

 

 

 

  15  

 

 

Future acquisitions and investments could disrupt our business and harm our financial condition and operating results.

 

Our success will depend, in part, on our ability to expand our services and grow our business in response to changing technologies, customer demands, and competitive pressures. In some circumstances, we may choose to do so through the acquisition of complementary businesses and technologies rather than through internal development. The identification of suitable acquisition candidates can be difficult, time-consuming and costly, and we may not be able to successfully complete identified acquisitions. The risks we face in connection with acquisitions include:

 

  · diversion of management time and focus from operating the business to addressing acquisition integration challenges; coordination of research and development and sales and marketing functions;

 

  · retention of key employees from the acquired company;

 

  · cultural challenges associated with integrating employees from the acquired company into our organization;

 

  · integration of the acquired company’s accounting, management information, human resources and other administrative systems;

 

  · the need to implement or improve controls, procedures and policies at a business that prior to the acquisition may have lacked effective controls, procedures and policies;

 

  · liabilities for activities of the acquired company before the acquisition, including intellectual property infringement claims, violations of laws, commercial disputes, tax liabilities, and other known and unknown liabilities;

 

  · unanticipated write-offs or charges; and

 

  · litigation or other claims in connection with the acquired company, including claims from terminated employees, customers, former stockholders or other third parties.

 

Our failure to address these risks or other problems encountered in connection with our past or future acquisitions and investments could cause us to fail to realize the anticipated benefits of these acquisitions or investments, cause us to incur unanticipated liabilities, and harm our business generally. Future acquisitions could also result in dilutive issuances of our equity securities, the incurrence of debt, contingent liabilities, amortization expenses, incremental operating expenses or the write-off of goodwill, any of which could harm our financial condition or operating results.

 

Unfavorable general economic conditions in the United States or in other major markets could negatively impact our financial performance.

 

Unfavorable general economic conditions, such as a recession or economic slowdown in the United States or in other major markets, could negatively affect the affordability of, and consumer demand for our services. Under difficult economic conditions, consumers may seek to reduce discretionary spending by forgoing purchases of our services or by shifting away from our platform to lower-priced products or services offered by other companies. Softer consumer demand for our services in the United States or in other major markets could reduce our profitability and could negatively affect our financial performance.

 

Many individuals use mobile devices to access online services. If users of these devices do not widely adopt the proprietary platform we develop for these devices or if we are unable to effectively operate on mobile devices, our business could be adversely affected.

 

The number of people who access online services through mobile devices, such as smart phones, handheld tablets and mobile telephones, as opposed to personal computers, has increased dramatically in the past few years and is projected to continue to increase. If the mobile solutions we have developed do not meet the needs of prospective and current customers, they may not sign up or reduce their usage of our platform and our business could suffer. Additionally, we are dependent on the interoperability of our proprietary platform with popular mobile operating systems that we do not control, such as Android and iOS, and any changes in such systems and terms of service that degrade our solutions’ functionality, or give preferential treatment to competitive products, could adversely affect traffic and monetization on mobile devices. We may not be successful in maintaining and developing relationships with key participants in the mobile industry or in developing products that operate effectively with these technologies, systems, networks, or standards. Each manufacturer or distributor may establish unique technical standards for its devices, and our products and services may not work or be viewable on these devices as a result. Some manufacturers may also elect not to include our products on their devices. As new devices and new platforms are continually being released, it is difficult to predict the challenges we may encounter in developing versions of our solutions for use on these alternative devices, and we are devoting significant resources to the support and maintenance of such devices.

 

 

 

  16  

 

 

Our solutions and internal systems rely on software that is highly technical, and if it contains undetected errors, our business could be adversely affected.

 

Our solutions and internal systems rely on software that is highly technical and complex. In addition, our solutions and internal systems depend on the ability of our software to store, retrieve, process, and manage immense amounts of data. Our software has contained, and may now or in the future contain, undetected errors, bugs, or vulnerabilities. Some errors in our software may only be discovered after the code has been released for external or internal use. Errors or other design defects within our software may result in a negative experience for members or customers, delay product introductions or enhancements, or result in measurement or other errors. Any errors, bugs, or defects discovered in our software could result in damage to our reputation, loss of members, loss of revenue, or liability for damages, any of which could adversely affect our business and financial results.

 

We face competition in the market from social networking sites and Internet search companies, among others, as well as continued competition for customers.

 

We face significant competition in all aspects of our business, and we expect such competition to increase, particularly in the market for online professional networks and engagement of professionals.

 

Our industry is evolving rapidly and is becoming increasingly competitive. Larger and more established companies may focus on our market and could directly compete with us. Smaller companies, including application developers, could also launch new products and services that compete with us and that could gain market acceptance quickly. We may also face competition if we shift our focus of development to new or different products or separate areas of our business.

 

Anti-takeover provisions in our charter documents and under Nevada law could make an acquisition of us more difficult, limit attempts by our stockholders to replace or remove our current management and limit any eventual market price of our common stock.

 

Provisions in our amended and restated articles of incorporation and amended and restated bylaws may have the effect of delaying or preventing a change of control or changes in our management. Our articles of incorporation and bylaws include provisions that:

 

  · authorize our board of directors to issue, without further action by the stockholders, up to 10,000,000 shares of undesignated preferred stock;

 

  · specify that special meetings of our stockholders can be called only by the President, Vice President, or a majority of the board of directors, and shall be called at the request of stockholders holding a majority of the capital stock of Dthera; and

 

  · provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum.

 

These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, institutional shareholder representative groups, shareholder activists and others may disagree with our corporate governance provisions or other practices, including our dual class structure and the other anti-takeover provisions, such as those listed above. We generally will consider recommendations of institutional shareholder representative groups, but we will make decisions based on what our board and management believe to be in the best long term interests of our company and stockholders. Our dual class structure concentrates the voting power of our stock in a small group of stockholders who would have the ability to control the outcome of a stockholder vote. Additionally, these groups could make recommendations to our stockholders against our practices or our board members if they disagree with our positions.

 

The forward looking statements contained in this Report may prove incorrect.

 

This Report contains certain forward-looking statements. These forward-looking statements are based largely on our current expectations and are subject to a number of risks and uncertainties. Actual results could differ materially from these forward-looking statements. In addition to the other risks described elsewhere in this “Risk Factors” discussion, important factors to consider in evaluating such forward-looking statements include: (i) changes to external competitive market factors or in our internal budgeting process which might impact trends in our results of operations; (ii) anticipated working capital or other cash requirements; (iii) changes in our business strategy or an inability to execute our strategy due to unanticipated changes in our industry; and (iv) various competitive factors that may prevent us from competing successfully in the marketplace. In light of these risks and uncertainties, many of which are described in greater detail elsewhere in this “Risk Factors” discussion, there can be no assurance that the events predicted in forward-looking statements contained in this Report will, in fact, transpire. Any negative change in the factors listed above could adversely affect the financial condition and operating results of Dthera and its products.

 

 

 

  17  

 

 

Risks Relating to Ownership of Our Common Stock

 

We have not paid, and do not intend to pay, dividends on our common stock and therefore, unless our common stock appreciates in value, our investors may not benefit from holding our common stock.

 

We have not paid any cash dividends on our common stock since inception. We do not anticipate paying any cash dividends our common stock in the foreseeable future. As a result, investors in our common stock will not be able to benefit from owning our common stock unless the market price of our common stock becomes greater than the price paid for the stock by investors.

 

The public trading market for our common stock is volatile and may result in higher spreads in stock prices, which may limit the ability of our investors to sell their shares at a profit, if at all.

 

Our common stock trades in the over-the-counter market and is quoted on the OTC Pink Sheets, with little trading volume or activity. The over-the-counter market for securities has historically experienced extreme price and volume fluctuations during certain periods. These broad market fluctuations may adversely affect the market price of our common stock and result in substantial losses to our investors. In addition, the spreads on stock traded through the over-the-counter market are generally unregulated and higher than on stock exchanges, which means that the difference between the price at which shares could be purchased by investors in the over-the-counter market compared to the price at which they could be subsequently sold would be greater than on these exchanges. Significant spreads between the bid and asked prices of the stock could continue during any period in which a sufficient volume of trading is unavailable or if the stock is quoted by an insignificant number of market makers. Historically, our trading volume has been insufficient to significantly reduce this spread and we have had a limited number of market makers sufficient to affect this spread. These higher spreads could adversely affect investors who purchase the shares at the higher price at which the shares are sold, but subsequently sell the shares at the lower bid prices quoted by the brokers. Unless the bid price for the stock exceeds the price paid for the shares by the investor, plus brokerage commissions or charges, the investor could lose money on the sale. For higher spreads such as those on over-the-counter stocks, this is likely a much greater percentage of the price of the stock than for exchange listed stocks. There is no assurance that at the time an investor in our common stock wishes to sell the shares, the bid price will have sufficiently increased to create a profit on the sale.

 

We do not know whether a market for our common stock will be sustained or what the market price of our common stock will be and as a result it may be difficult for investors to sell their shares of our common stock.

 

Although our common stock is eligible for quotation on the OTC Pink, an active trading market for our shares has not commenced and may not be sustainable. It may be difficult for investors to sell their shares without depressing the market price for the shares or at all. As a result of these and other factors, investors may not be able to sell their shares at or above the offering price or at all. Further, an inactive market may also impair our ability to raise capital by selling shares of our common stock and may impair our ability to enter into strategic partnerships or acquire companies or products by using our shares of common stock as consideration. If an active market for our common stock does not develop or is not sustained, it may be difficult to sell your common stock.

 

Our Board can, without stockholder approval, cause preferred stock to be issued on terms that adversely affect common stockholders or which could be used to resist a potential take-over of the Company.

 

Under our Articles of Incorporation, our Board is authorized to issue up to 1,000,000 shares of preferred stock, none of which were issued and outstanding as of the date of this Report. (The Company had previously designated 150,000 shares of Series A Preferred Stock, but all had been converted into shares of the Company’s common stock as of the date of this Report.) Also, our Board, without stockholder approval, may determine the price, rights, preferences, privileges and restrictions, including voting rights, of those shares. If the Board causes shares of preferred stock to be issued, the rights of the holders of our common stock could be adversely affected. The Board’s ability to determine the terms of preferred stock and to cause its issuance, while providing desirable flexibility in connection with possible acquisitions and other corporate purposes, could have the effect of making it more difficult for a third party to acquire a majority of our outstanding voting stock. Preferred shares issued by the Board could include voting rights, or even super voting rights, which could shift the ability to control the Company to the holders of the preferred stock. Preferred shares could also have conversion rights into shares of common stock at a discount to the market price of the common stock which could negatively affect the market for our common stock. In addition, preferred shares would have preference in the event of liquidation of the corporation, which means that the holders of preferred shares would be entitled to receive the net assets of the corporation distributed in liquidation before the common stock holders receive any distribution of the liquidated assets. We have no current plans to issue any shares of preferred stock.

 

 

 

  18  

 

 

The market price of our common stock may fluctuate significantly, which could result in substantial losses by our investors.

 

The market price of our common stock may fluctuate significantly in response to numerous factors, some of which are beyond our control, such as:

 

  · announcements of technological innovations, new products or product enhancements by us or others;

 

  · announcements by us of significant strategic partnerships, out-licensing, in-licensing, joint ventures, acquisitions or capital commitments;

 

  · expiration or terminations of licenses, research contracts or other collaboration agreements;

 

  · public concern as to the safety of products we, our licensors or others develop;

 

  · success of research and development projects;

 

  · developments concerning intellectual property rights or regulatory approvals;

 

  · variations in our and our competitors’ results of operations;

 

  · changes in earnings estimates or recommendations by securities analysts, if our common stock is covered by analysts;

 

  · changes in government regulations or patent decisions;

 

  · developments by our licensors;

 

  · developments in the technology industry;

 

  · the results of product liability or intellectual property lawsuits;

 

  · future issuances of common stock or other securities;

 

  · the addition or departure of key personnel;

 

  · announcements by us or our competitors of acquisitions, investments or strategic alliances;

 

  · general market conditions, including the volatility of market prices for shares of technology companies generally, and other factors, including factors unrelated to our operating performance; and

 

  · the other factors described in this “Risk Factors” section.

 

These factors and any corresponding price fluctuations may materially and adversely affect the market price of our common stock and result in substantial losses by our investors.

 

Further, the stock market in general, and the market for technology companies in particular, has experienced extreme price and volume fluctuations in the past. Continued market fluctuations could result in extreme volatility in the price of our common stock, which could cause a decline in the value of our common stock. Price volatility of our common stock might be worse if the trading volume of our common stock is low. In the past, following periods of market volatility, stockholders have often instituted securities class action litigation. If we were involved in securities litigation, it could have a substantial cost and divert resources and attention of management from our business, even if we are successful. Future sales of our common stocks could also reduce the market price of such stock.

 

Moreover, the liquidity of our common stock is limited, not only in terms of the number of shares that can be bought and sold at a given price, but by delays in the timing of transactions and reduction in security analysts’ and the media’s coverage of us, if any. These factors may result in lower prices for our common stock than might otherwise be obtained and could also result in a larger spread between the bid and ask prices for our common stock. In addition, without a large float, our common stock is less liquid than the stock of companies with broader public ownership and, as a result, the trading prices of our common stock may be more volatile. In the absence of an active public trading market, an investor may be unable to liquidate its investment in our common stock. Trading of a relatively small volume of our common stock may have a greater impact on the trading price of our stock than would be the case if our public float were larger. We cannot predict the prices at which our common stock will trade in the future.

 

 

 

  19  

 

 

Some or all of the “restricted” shares of our common stock issued in connection with the Acquisition or held by other of our stockholders may be offered from time to time in the open market pursuant to an effective registration statement or Rule 144 promulgated under Regulation D of the Securities Act, and these sales may have a depressive effect on the market for our common stock.

 

Raising additional capital by issuing securities may cause dilution to existing stockholders.

 

We will need to raise substantial future capital to continue to complete development and commercialize our products incorporating licensed technologies and technology candidates and to conduct the research and development and regulatory activities necessary to bring our technology candidates to market.

 

If we raise additional funds through licensing arrangements with third parties, we may have to relinquish valuable rights to our technology candidates, or grant licenses on terms that are not favorable to us. If we raise additional funds by issuing equity or convertible debt securities, we will reduce the percentage ownership of our then-existing stockholders, and these securities may have rights, preferences or privileges senior to those of our existing stockholders.

 

Because our common stock may be a “penny stock,” it may be more difficult for investors to sell shares of our common stock, and the market price of our common stock may be adversely affected.

 

Our common stock may be a “penny stock” if, among other things, the stock price is below $5.00 per share, it is not listed on a national securities exchange or it has not met certain net tangible asset or average revenue requirements. Broker-dealers who sell penny stocks must provide purchasers of these stocks with a standardized risk-disclosure document prepared by the SEC. This document provides information about penny stocks and the nature and level of risks involved in investing in the penny-stock market. A broker must also give a purchaser, orally or in writing, bid and offer quotations and information regarding broker and salesperson compensation, make a written determination that the penny stock is a suitable investment for the purchaser, and obtain the purchaser’s written agreement to the purchase. Broker-dealers must also provide customers that hold penny stock in their accounts with such broker-dealer a monthly statement containing price and market information relating to the penny stock. If a penny stock is sold to an investor in violation of the penny stock rules, the investor may be able to cancel its purchase and get its money back.

 

If applicable, the penny stock rules may make it difficult for investors to sell their shares of our common stock. Because of the rules and restrictions applicable to a penny stock, there is less trading in penny stocks and the market price of our common stock may be adversely affected. Also, many brokers choose not to participate in penny stock transactions. Accordingly, investors may not always be able to resell their shares of our common stock publicly at times and prices that they feel are appropriate.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS.

 

Not applicable.

 

ITEM 2. PROPERTIES.

 

Our principal offices are located at 7310 Miramar Rd., Suite 350, San Diego, CA 92126. The lease payments are $1,000 per month, and are on a month-to-month basis, with no long-term lease in place. Management believes that the Company is on good terms with the landlord, and will continue to evaluate and balance the needs for office space and the costs and risk associated with additional space.

 

ITEM 3. LEGAL PROCEEDINGS.

 

Neither we nor our subsidiary, EveryStory, is a party to, nor is any of their property subject to, any legal proceedings which require disclosure pursuant to this item.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

 

 

  20  

 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

Market Information

 

Our Common Stock is quoted on the OTC Markets under the symbol “DTHR.” The Company’s common stock was approved for quotation on June 18, 2014. As of the date of this Report, an active trading in the Company’s common stock had not developed.

 

Holders

 

As of April 16, 2017, there were approximately 101 stockholders. This number does not include an indeterminate number of stockholders whose shares are held by brokers in street name. The holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders. Holders of our common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to our common stock.

 

Dividends

 

We have not paid, nor declared, any cash dividends since our inception and do not intend to declare or pay any such dividends in the foreseeable future. Our ability to pay cash dividends is subject to limitations imposed by state law.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

As of the transition year ended December 31, 2016, the Company had no compensation plans (including individual compensation arrangements) under which our Common Stock was authorized for issuance. The Company’s subsidiary, EveryStory, had an incentive stock and stock option plan, pursuant to which shares of EveryStory common stock were or could be issued. However, pursuant to the transaction with EveryStory discussed herein, all shares of EveryStory common stock were exchanged for shares of the Company’s common stock. The EveryStory stock options were converted into Dthera options on September 21, 2016, pursuant to the A&R Agreement.

 

Recent sales of unregistered securities

 

On April 10, 2017, the Company closed a private placement offering (the “Private Offering”) in which the Company raised gross proceeds of approximately $1,233,900 The Company sold an aggregate of 7,119,500 shares of its common stock in the Private Offering to approximately 27 investors. The Company’s officers and directors conducted the offering, and worked with a placement agent in connection with several of the investors. All of the investors signed agreements indicating that they were accredited investors, that they were purchasing the Company’s shares for investment purposes and not with a view to distribute them, that they were purchasing for their own accounts and not for the accounts of others, that they were experienced in investing in early stage companies, and that they had been afforded sufficient opportunities to obtain information about the Company. The Company made available copies of its public filings in connection with a private placement memorandum.

 

The Private Offering was conducted in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), as well as rules and regulations promulgated thereunder based on the following factors: (i) the number of purchasers; (ii) the absence of general solicitation; (iii) investment representations obtained from the investors in the transaction; (iv) the provision of appropriate disclosures; and (v) the placement of restrictive legends on the certificates reflecting the securities sold.

 

ITEM 6. SELECTED FINANCIAL DATA.

 

As a “smaller reporting company,” we have elected not to provide the disclosure required by this item.

 

 

 

  21  

 

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Overview

 

On September 21, 2016, the Company acquired a new operating subsidiary, EveryStory, Inc., a Delaware corporation (“ EveryStory ”). The Company is developing a Digital Therapeutic technology designed to deliver Reminiscence Therapy to certain patient populations, principally patients suffering from Alzheimer’s disease and dementia with the goal of a Quality of Life benefit and reduction in anxiety in those populations. Prior to the closing of the EveryStory transaction, the Company was incorporated in the State of Nevada on December 27, 2012, to engage in the development and operation of a business engaged in the distribution of high end edged tools produced outside the US. We conducted this business through October 22, 2014. On October 22, 2014, we acquired an operating subsidiary, Knowledge Machine, Inc., a Nevada corporation, (“ Knowledge Machine ”), which focused on new technologies, acquiring licensing rights to those technologies, and marketing the licensed technologies, and we sold off our edged tools business. In connection with the EveryStory transaction, we dissolved Knowledge Machine, and terminated the technology licensing and marketing operations.

 

Change in Fiscal Year End

 

As noted above, on November 12, 2016, the Board of Directors approved a change in fiscal year-end of the Company from a June 30 year-end to a calendar year-end of December 31. The Board of Directors’ decision to change the fiscal year-end is intended to assist the financial community in its analysis of the business and in comparing Dthera’s financial results to others in the industry, and to synchronize the Company's fiscal reporting period with the Securities and Exchange Commission's required year-end reserve reporting period of December 31. Additionally, the Company’s principal operating subsidiary, EveryStory, Inc., has a December 31 year end, and because the Company’s principal operations are focused on the implementation of the EveryStory Platform, and because EveryStory’s financial statements are prepared on a calendar year end basis, the Board of Directors determined it to be in the best interests of the Company to not have to re-audit the EveryStory financial statements to reflect a June 30 year end. As such, the Board of Directors approved the change.

 

As of November 12, 2016, the date of the Company's fiscal year-end was changed to December 31. Accordingly, the Company filed a transitional quarterly report on Form 10-QT, reflecting the period ended September 30, 2016, as the third quarter rather than the first quarter, and is filing this transitional annual report on Form 10-KT for the fiscal year ended December 31, 2016.

 

Dthera Business and Platform

 

Key components of the Platform include the ability to record audio narratives that are linked to specific photos and which can be played when the photos are viewed; the ability to import photos directly from computers or mobile devices; cloud-based data storage of the photos and the audio recordings; and multiple playback capabilities; collaborative creation and sharing of stories. The Platform was designed for mobile device platforms to enable users to record and store photos and audio easily and conveniently.

 

The Company’s technology Platform streamlines the creation of personalized digital stories, and management is focused on the goal of becoming the first clinically-proven Digital Therapeutic technology targeting patients with Alzheimer's disease and Dementia. EveryStory already has received a US patent (issued in 2010) that broadly covers the use of EveryStory’s technology in Senior Living facilities. The Company has recently concluded a clinical trial with UCSD which produced positive results indicating that the Company’s ReminX Platform is an effective anxiety reduction and quality of life therapy for those with Alzheimer’s disease or Dementia (“ADOD”).

 

EveryStory conducts its operations from its facilities located in San Diego, California.

 

Plan of Operations

 

Revenue Model

 

Digital Therapeutics Business Model

 

Dthera intends to offer the Digital Therapeutics technology directly to the families of ADOD patients as a clinical supported therapy. Additionally, Dthera intends to partner directly with Senior Living management firms, to introduce to the resident and the resident’s families starting in the summer of 2017.

 

 

 

  22  

 

 

In both the direct-to-Patient and the Senior Living-management models, management anticipates that the product, which will include a digital tablet in the patient’s room, with monthly and/or yearly rates for participation in the program.

 

Additionally, Dthera intends to seek partners in international markets to help make introductions to the Senior Living-type markets and other implementation techniques.

 

Once Dthera has begun implementation of the Digital Therapeutics and Reminiscence Therapy applications of the Platform, Dthera’s management intends to further explore other applications of the Platform targeting other indications with patients that could benefit from the core technology.

 

Results of Operations

 

Year Ended December 31, 2016 Compared to the Year Ended December 31, 2015

 

As noted above, the information below relating to historical data for the periods ended December 31, 2016 and 2015, relate to the operations of the Company’s subsidiary, EveryStory, and not to the prior business and operations of Knowledge Machine International, Inc., which were terminated following the closing of the EveryStory Transaction on September 21, 2016.

 

Gross Revenue . Gross revenue for the years ended December 31, 2016 and 2015 was $0. Accordingly, there were no costs of goods sold. The Company was previously operating in the cutlery sales market but that business was sold and a new operating subsidiary was acquired which is operating in the technology market. This new line of business is in the development stage and has not yet recognized any revenue.

 

Operating Expenses

 

General and Administrative Expenses

General and administrative expenses for the year ended December 31, 2016 totaled $690,248, a 17% increase compared to general and administrative expenses of $590,569 for the year ended December 31, 2015. The increase is primarily due to the Company’s increase of stock option expense recognized in the current year.

 

Professional Fees

Professional fees for the year ended December 31, 2016 totaled $343,694, a 120% increase compared to professional fees of $156,573 for the year ended December 31, 2015. The increase is primarily due to the legal and audit fees related to the A&R Agreement.

 

Other Expenses

 

Interest Expense

Interest expense for the year ended December 31, 2016, totaled $126,115, a 491% increase compared to interest expenses of $21,350 for the year ended December 31, 2015. The increase is due to an increase in notes payable, resulting in an increase of accrued interest and the amortization of debt discounts in the current period.

 

Derivative Expense

Derivative expense for the year ended December 31, 2016, totaled $37,616, a 100% increase compared to derivative expense of $0 for the year ended December 31, 2015. The increase is due to the Company’s entering into four convertible debt instruments during the current period with a derivative liability.

 

Gain on Derivative Liability

Gain on derivative liability for the year ended December 31, 2016, totaled $33,114, a 100% increase compared to gain on derivative liability of $0 for the year ended December 31, 2015. The increase is due to the change in value of the derivative liability on re-measurement at period end.

 

Gain on Settlement of Debt

Gain on settlement of debt for the year ended December 31, 2016, totaled $34,875, a 100% increase compared to gain on settlement of debt of $0 for the year ended December 31, 2015. The increase is due to the settlement of accrued consulting fees of $60,000 through EveryStory issuing 37,500 shares of its common stock, which were exchanged for 263,325 shares of Dthera common stock valued at $25,125.

 

 

 

  23  

 

 

Impairment of Intangible Assets

Impairment of intangible assets for the year ended December 31, 2016, totaled $58,960, a 730% increase compared to impairment of intangible assets of $7,100 for the year ended December 31, 2015. The increase is due to the Company’s impairing the intangible asset purchase with stock in the current period.

 

Net Loss

 

 For the reasons stated above, the Company’s net loss for the year ended December 31, 2016, was $1,194,804, compared to net loss of $776,507 during the year ended December 31, 2015.

 

Liquidity and Capital Resources

 

As of year ended December 31, 2016, the Company had cash of $12,191 and deposits of $1,000. The Company had current liabilities of $593,926 consisting of accounts payable and accrued expenses, derivative liability, notes payable and convertible notes payable. As of year ended December 31, 2016, the Company had a working capital deficit of $580,735.

 

The accompanying financial statements have been prepared contemplating a continuation of the Company as a going concern. The Company had ongoing operations during from inception to December 31, 2016, with an accumulated deficit of $1,978,400.

 

Off-Balance Sheet Arrangements

 

The Company has no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

As a “smaller reporting company”, we have elected not to provide the disclosure required by this item.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 

The required financial statements are included following the signature page of this Annual Report on Form 10-K.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 

On November 8, 2016, the Company notified Pritchett Siler & Hardy, P.C. (“PSH”), an independent registered public accounting firm, that effective as of November 8, 2016, the Company had decided to dismiss PSH as the Company’s independent registered public accounting firm. The decision to dismiss PSH was made and approved by the Company’s Board of Directors.

 

The audit reports of PSH on the Company's financial statements for the fiscal years ended June 30, 2016 and 2015, did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to audit scope, or accounting principles, except that the PSH reports for these fiscal years ended contained a going concern uncertainty. This uncertainty expressed substantial doubt about the Company's ability to continue as a going concern based on working capital deficits and the lack of profitable operations.

 

During the two most recent fiscal years and through November 8, 2016, the Company had no disagreements with PSH on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement, if not resolved to their satisfaction, would have caused PSH to make reference to the subject matter of the disagreement in connection with its reports. In addition, during that time there were no reportable events (as defined in Item 304(a)(1)(v) of Regulation S-K).

 

The Company has provided PSH with a copy of the disclosures required by Item 304(a) contained in this Report on Form 8-K and has requested that PSH furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether PSH agrees with the statements made by the registrant in this Form 8-K and, if not, stating the respects in which it does not agree. A copy of PSH’s letter dated November 10, 2016, was filed as Exhibit 16.1to the Company’s Current Report on Form 8-K filed November 15, 2016.

 

 

 

 

  24  

 

 

Effective as of November 8, 2016, the Company engaged Sadler, Gibb & Associates, LLC (“Sadler Gibb”) as its new independent registered public accounting firm. The decision to engage Sadler Gibb was made and approved by the Company's Board of Directors. The headquarters office of Sadler Gibb is located in Salt Lake City, Utah, and Sadler Gibb is registered with the Public Company Accounting Oversight Board.

 

During the two most recent fiscal years and through November 8, 2016, the Company had not consulted with Sadler Gibb regarding either: (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements or (ii) any matter that was either subject of a disagreement (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K) or a reportable event (as that term is described in Item 304(a)(1)(v) of Regulation S-K).

 

ITEM 9A. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our prior principal executive and financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 15d-15(e) of the Securities Exchange Act of 1934, as amended, the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and principal financial officer concluded that our disclosure controls and procedures as of the end of the period covered by this report (based on the evaluation of these controls and procedures required by Rule 15d-15(b) of the Exchange Act) were not effective in ensuring that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, and (ii) is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period covered by the Report, we did not have a formal audit committee and there was a lack of segregation of duties.

 

We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of our company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Management assessed our internal control over financial reporting as of June 30, 2016, the end of our fiscal year. Management based its assessment on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO 2013 Criteria) . Management’s assessment included evaluation of such elements as the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies, and our overall control environment.

 

Based on our assessment, management has concluded that our internal control over financial reporting was not effective, as of the end of the fiscal year, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles.

 

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this annual report.

 

 

 

  25  

 

 

Inherent limitations on effectiveness of controls

 

Internal control over financial reporting has inherent limitations which include but is not limited to the use of independent professionals for advice and guidance, interpretation of existing and/or changing rules and principles, segregation of management duties, scale of organization, and personnel factors. Internal control over financial reporting is a process which involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements on a timely basis, however these inherent limitations are known features of the financial reporting process and it is possible to design into the process safeguards to reduce, though not eliminate, this risk. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Changes in Internal Control Over Financial Reporting

 

There was no change in our internal control over financial reporting (as defined in Rule 15d-15(f) of the Exchange Act) that occurred during the year ended December 31, 2016, that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

None.

 

 

 

  26  

 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

 

The following table sets forth information concerning our executive officers and directors, each of whom was appointed effective September 21, 2016:

 

Name Age Title
Edward Cox 36 Director, Chairman, President, and CEO
David Keene 40 Director, Chief Technical Officer
Larry Morgan 66 Director

 

The Board believes that each director named below is highly qualified and has the skills and experience required for effective service on the Board. The directors’ individual biographies below contain information about their experience, qualifications and skills that led the Board to appoint them.

 

Edward Cox , age 36, has served as our President, Chief Executive Officer, Chairman, and a director since September 21, 2016. In addition, he has served as President, Chief Executive Officer, Chairman, and a director of EveryStory since February 6, 2015. Prior to that, he served as a Vice President and Executive Officer of Apricus Biosciences, Inc., a publicly traded company, since December 2009, in roles leading Commercial Development, Business Development, Investor Relations, and Corporate Development. Mr. Cox served as the President, Director and Secretary of Bio-Quant, Inc. from January 2007 until BioQuant’s merger with NexMed, Inc., which was renamed Apricus Biosciences. Prior to 2007, Mr. Cox previously served as an executive or board member of both public and private companies in the areas of Healthcare, Life Science, Technology and Resources. Mr. Cox holds a Master of Science in Management degree from the Warrington College of Business Administration at the University of Florida.

 

David Keene , age 40, has served as our Chief Technology Officer and as a director since September 21, 2016. In addition, he is the founder, Chief Technology Officer and a member of the Board of Directors of EveryStory, is a veteran of the video game industry who has specialized in commerce and content delivery. Prior to founding EveryStory, from 2010 to 2013, Mr. Keene served as Chief Architect – Commerce Platform for Trion Worlds, Inc. (fka Trion World Networks, Inc.). At Trion, Mr. Keene led a group of senior engineers through the design and architecture process to create an innovative, world class commerce platform. Mr. Keene also created a high capability MTX platform that supported complex promotions, asymmetrical subscriptions, multiple game-specific currencies and robust reporting. While at Trion, Mr. Keene also had direct management responsibility over the quality assurance engineering team that created a third party order testing platform (custom DSL) for fully automated testing on all development. Prior to Trion, from 2006 to 2010, Mr. Keene served as Senior Architect – PlayStation Network for Sony Network Entertainment (“ SNE ”). While at SNE, Mr. Keene managed integrations with multiple SNE global partner groups, added search to the PlayStation Network (“ PSN ”) through soir/lucene, implemented an innovative recommendation system that avoided IP risk exposure. Mr. Keene also defined and led development guidance for the VERSA API, a RESTful api for next-gen PSN products and the Sony Qriosity video service. Prior to SNE, from 2004 to 2006, Mr. Keene served as a Senior Engineer at Sony Online Entertainment, where he worked supported the launch of several massively multiplayer online games (“ MMOs ”) including EverQuest II. Prior to that, from 2001 to 2004, Mr. Keene served as an independent software consultant and as a Senior Database Engineer for Shea Homes, a California-based home builder.

 

Larry Morgan , age 66, has served as a director since September 21, 2016. In addition, he joined the EveryStory board of directors in 2015. Mr. Morgan is a top-flight executive with over 25 years of global experience in the telecom, IT services, enterprise restructuring, and consulting industries. Mr. Morgan is currently President and CEO of The Noble Group, a consulting firm that advises early stage companies on growth strategies and advises the managements of seasoned companies regarding exit strategies. Mr. Morgan is also an active investor with Vertical Venture Partners, Tech Coast Angels and OurCrowd. From 2010 to 2013 Mr. Morgan served as Executive Director of San Diego Data Processing Corporation and led a restructuring that resulted in annual savings in excess of $11 million to the City of San Diego. Prior to that, from 2007 to 2009, Mr. Morgan served as a Managing Director of Macquarie Telecom, where he led the turnaround of the international hosting, voice and data outsourcing division and led the sale of the resulting profitable business. In addition to domestic postings, during his tenure with Macquarie, Mr. Morgan had postings in Australia and Singapore, Prior to Macquarie, from 2005 to 2006, Mr. Morgan served as President and CEO of Virtela Communications, spearheading the turnaround that resulted in the foundation for Virtela’s eventual sale for over $500 million. Prior to Virtela, from 1991 to 2005, Mr. Morgan had several executive positions of increasing responsibility with Infonet Services Corporation, and last served as Corporate Vice President and General Manager. During his tenure with Infonet, Mr. Morgan led Infonet’s business in Europe, the Middle East and Africa, was responsible for all IP, outsourcing and cloud computing products, expansion into India, network coverage in 61 countries, and was a member of the executive due diligence and transition team in connection with the company’s sale to British Telecom for $965 million. Also during his tenure with Infonet, Mr. Morgan had international postings in The Netherlands and Singapore. Mr. Morgan holds both a B.S. degree (Mathematics and Education) and an M.A. degree (Administration) from Villanova University.

 

 

  27  

 

 

The term of our directors’ appointment is until the next annual meeting of shareholders or until their successors are duly elected and qualified. At this time, there are no plans to appoint our directors to any committees.

 

Legal Proceedings

 

During the past ten years there have been no events under any bankruptcy act, no criminal proceedings and no judgments, injunctions, orders or decrees material to the evaluation of the ability and integrity of any of our directors or executive officers.

 

We are not aware of any legal proceedings in which any director, officer or affiliate of our Company, any owner of record or beneficially of more than five percent of any class of our voting securities, or any associate of any such director, officer, or affiliate of our Company, or security holder is a party adverse to us or our subsidiaries or has a material interest adverse to us or our subsidiaries.

 

Family Relationships

 

There are no family relationships between any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer.

 

ITEM 11. EXECUTIVE COMPENSATION

 

Executive Compensation

 

The following table sets forth information concerning the annual compensation awarded to, earned by, or paid to the named executive officer for all services rendered in all capacities to our Company and its subsidiaries for the years ended December 31, 2016 and 2015:

 

SUMMARY COMPENSATION TABLE

 

Name and Principal Position   Year Ended
December 31,
    Salary
($)
   

 

Stock
Awards ($)
    Total
($)
 
Edward Cox,     2016     $ 0     $ 0     $ 0  
Chief Executive Officer     2015     $ 0     $ 0     $ 0  
                                 
David Keene,     2016     $ 8,200 (1)   $ 0     $ 8,200  
Chief Technical Officer    

2015

  $ 0     $ 0     $ 0  

 

(1) Mr. Keene was paid a total of $8,200 in Q4 2016 as consulting fees, rather than salary, for software development. Additionally, Mr. Keene was paid $13,000 in the first quarter of 2017 for software development work.

 

 

 

  28  

 

 

Outstanding Equity Awards at Fiscal Year End (December 31, 2016)

 

Outstanding Equity Awards at Fiscal Year-End

 

Name Option awards Stock awards
Number of
securities
underlying
unexercised
options

(#) exercisable
Number of
securities

underlying
unexercised
options
(#)
unexercisable
Equity
incentive
plan
awards:
Number of

securities
underlying
unexercised
unearned
options
(#)
Option
exercise
price

($)
Option
expiration date
Number of
shares or
units of
stock that
have not
vested

(#)
Market
value of
shares of
units of
stock that
have not
vested

($)
Equity
incentive
plan
awards:
Number of

unearned
shares,
units or
other rights that have not vested

(#)
Equity
incentive
plan
awards:
Market
or payout
value of

unearned
shares,
units or other
rights that
have not vested

($)
(a) (b) (c) (d) (e) (f) (g) (h) (i) (j)
Edward Cox N/A N/A
David Keene N/A N/A
Larry Morgan N/A N/A
Vivek R. Dave N/A N/A

 

No named executive officer held any unexercised options, stock that had not vested, or equity incentive plan awards at December 31, 2016.

 

Director Compensation

 

Neither Mr. Cox nor Mr. Keene received any compensation for their services as directors of the Company. All compensation paid to Mr. Cox and Mr. Keene was in connection with their services as officers of the Company, outlined above.

 

 

 

  29  

 

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 

The following table sets forth certain information furnished by current management and others, concerning the beneficial ownership of our common stock as of April 12, 2017, of (i) each person who is known to us to be the beneficial owner of more than five percent of our common stock; (ii) all directors and named executive officers; and (iii) our directors and executive officers as a group. The percentages below are based on a total of 35,841,586 shares outstanding as of April 12, 2017.

 

Name and Address of

Beneficial Owner

Amount and Nature of

Beneficial Ownership (1)

Percent of Class (1)
     

Vivek R. Dave, Former Officer and Director

14 Hayward Brook Drive

Concord, NH 03301

766,761 2.08%
     

Edward Cox, CEO, Director

9921 Carmel Mountain Road, Suite 118

San Diego, CA 92129

6,301,357 17.10%
     

 

David Keene, Director

9921 Carmel Mountain Road, Suite 118

San Diego, CA 92129

7,701,659 20.90%
     

Larry Morgan, Director

9921 Carmel Mountain Road, Suite 118

San Diego, CA 92129

398,683 1.08%
     

Named Executive Officers, Executive Officers, and

Directors as a Group

(3 Persons)

14,401,699 39.09%

 

 

(1) This table is based upon information supplied by officers, directors and principal stockholders and is believed to be accurate. Unless otherwise indicated in the footnotes to this table, we believe that each of the stockholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Shares of common stock subject to options, warrants, or other conversion privileges currently exercisable or convertible, or exercisable or convertible within 60 days of the date of this table, are deemed outstanding for computing the percentage of the person holding such option, warrant, or other convertible instrument but are not deemed outstanding for computing the percentage of any other person. Where more than one person has a beneficial ownership interest in the same shares, the sharing of beneficial ownership of these shares is designated in the footnotes to this table. As of March 31, 2017, we had 35,841,586 shares outstanding.

 

 

 

  30  

 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE.

 

Certain Relationships and Related Transactions

 

None.

 

Director Independence

 

Our securities are not listed on a national securities exchange or in an inter-dealer quotation system which has requirements that directors be independent. Therefore, we have adopted the independence standards of the American Stock Exchange, now known as the NYSE MKT LLC, to determine the independence of our directors and those directors serving on our committees. These standards provide that a person will be considered an independent director if he or she is not an officer of the company and is, in the view of the company’s board of directors, free of any relationship that would interfere with the exercise of independent judgment. Our board of directors has determined that Mr. Morgan meets this standard, and therefore, would be considered to be independent.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

 

Audit Fees

 

The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for the audit of our annual financial statement and review of financial statements included in our 10-Q reports and services normally provided by the accountant in connection with statutory and regulatory filings or engagements were $36,000 for fiscal year ended December 31, 2016, and $27,345 for fiscal year ended December 31, 2015.

 

Audit-Related Fees

 

The aggregate fees billed in each of the last two fiscal years for assurance and related services by the principal accountant that are reasonably related to the performance of the audit or review of our financial statements that are not reported above were $28,412 for fiscal year ended December 31, 2016, and $0 for fiscal year ended December 31, 2015.

 

Tax Fees

 

The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning were $0 for fiscal year ended December 31, 2016, and $0 for fiscal year ended December 31, 2015.

 

All Other Fees

 

The aggregate fees billed in each of the last two fiscal years for products and services provided by the principal accountant, other than the services reported above were $0 for fiscal year ended December 31, 2016, and $0 for fiscal year ended December 31, 2015.

 

Audit Committee

 

As of the date of this Annual Report, the Company did not have a standing audit committee serving, and as a result our board of directors performs the duties of an audit committee. Our board of directors will evaluate and approve in advance, the scope and cost of the engagement of an auditor before the auditor renders audit and non-audit services. We do not rely on pre-approval policies and procedures. Additionally, as of the date of this Report the Company did not have an audit committee financial expert due to the size of the Company.

 

 

 

  31  

 

 

PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

 

  (a) Financial Statements Index

 

The following financial statements are filed with this report:

 

Report of Independent Registered Public Accounting Firm

 

Consolidated Balance Sheets at December 31, 2016 and 2015

 

Consolidated Statements of Operations for the years ended December 31, 2016 and December 31, 2015

 

Consolidated Statements of Cash Flows for the years ended December 31, 2016 and December 31, 2015

 

Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2016 and December 31, 2015

 

Notes to Consolidated Financial Statements

 

  (b) Exhibits

 

Exhibit
Number
Exhibit Description Form Exhibit Filing Date

Filed Here-

with

2.1 Agreement and Plan of Reorganization dated October 22, 2104 10-K 2.1 10/28/14  
2.2 Asset Purchase Agreement dated October 22, 2014 10-K 2.2 10/28/14  
2.3 Amended and Restated Acquisition and Share Exchange Agreement between Knowledge Machine International, Inc., and EveryStory, Inc., and the Shareholders of EveryStory, Inc., dated as of September 21, 2016 8-K 2.1 9/27/16  
3.1 Articles of Incorporation 10-K 3.1 10/28/14  
3.2 Bylaws S-1 3.2 9/16/13  
3.3 Certificate of Designation Establishing the Designation, Powers, Preferences, Limitations, Restrictions, and Relative Rights of Series A Preferred Stock, as filed with the Nevada Secretary of State on June 30, 2016 8-K 3.1 6/24/16  
3.4 Certificate of Amendment to Articles of Incorporation 8-K 3.1 10/6/16  
10.1 Amended and Restated Acquisition and Share Exchange Agreement 8-K 2.1 9/27/16  
10.2 Form of Convertible Promissory Note 8-K 99.1 9/27/16  
10.3 Form of Securities Purchase Agreement 8-K 99.2 9/27/16  
16.1 Letter from John Scrudato, CPA to the Securities and Exchange Commission dated October 28, 2014. 10-K 16.1 10/28/14  
16.2 Letter from Pritchett Siler & Hardy, P.C. 8-K 16.1 11/15/2016  
21.1 Subsidiaries       X
31.1 Rule 15d-14(a) Certification by Principal Executive Officer and Principal Financial Officer       X
32.1 Section 1350 Certification of Principal Executive Officer and Principal Financial Officer       X
101.INS XBRL Instance Document       X
101.SCH XBRL Taxonomy Extension Schema Document       X
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document       X
101.DEF XBRL Taxonomy Extension Definition Linkbase Document       X
101.LAB XBRL Taxonomy Extension Label Linkbase Document       X
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document       X

*Management contract, or compensatory plan or arrangement, required to be filed as an exhibit.

 

 

 

  32  

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  DTHERA SCIENCES
     
     
     
Date: April 17, 2017

By:

/s/ Edward Cox
    Edward Cox, Chief Executive Officer

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

NAME TITLE DATE
     
/s/ Edward Cox Chairman, Chief Executive Officer and President April 17, 2017
Edward Cox (Principal executive, financial, and accounting officer)  
     
/s/ David Keene Director, Chief Technical Officer April 17, 2017
David Keene    
     
/s/ Larry Morgan Director April 17, 2017
Larry Morgan    

 

 

 

  33  

 

 

INDEX TO FINANCIAL STATEMENTS

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM F-2
CONSOLIDATED BALANCE SHEETS F-3
CONSOLIDATED STATEMENTS OF OPERATIONS F-4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT F-5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS F-6
Notes to Consolidated Financial Statements F-7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  F- 1  

 

 

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

To the Board of Directors and Shareholders of

Dthera Sciences

 

We have audited the accompanying consolidated balance sheets of Dthera Sciences (“the Company”) as of December 31, 2016 and 2015, and the related consolidated statements of operations, stockholders’ deficit, and cash flows for each of the years in the two year period ended December 31, 2016. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Dthera Sciences as of December 31, 2016 and 2015, and the results of its operations and its cash flows for each of the years in the two year period ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America.

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has suffered net losses since inception and has accumulated a significant deficit. These factors raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

 

 

/s/ Sadler, Gibb & Associates, LLC

 

Salt Lake City, UT

April 17, 2017

 

 

 

  

 

  F- 2  

 

 

DTHERA SCIENCES

CONSOLIDATED BALANCE SHEETS

As of December 31,

   

 

    2016     2015  
ASSETS  
CURRENT ASSETS                
Cash   $ 12,191     $ 27,238  
Prepaid expenses           21,390  
Deposits     1,000       1,000  
TOTAL CURRENT ASSETS     13,191       49,628  
                 
LONG TERM ASSETS                
Property and equipment, net     914       1,648  
TOTAL LONG TERM ASSETS     914       1,648  
                 
TOTAL ASSETS   $ 14,105     $ 51,276  
                 
LIABILITIES AND STOCKHOLDERS' DEFICIT  
CURRENT LIABILITIES                
Accounts payable and accrued liabilities   $ 268,564     $ 167,958  
Accounts payable and accrued expenses, related party     3,515        
Derivative liability     234,502        
Notes payable-related party           61,064  
Notes payable     20,000        
Current portion of convertible notes payable-related party, net           29,114  
Current portion of convertible notes payable, net     67,345       189,243  
TOTAL CURRENT LIABILITIES     593,926       447,379  
                 
LONG TERM LIABILITIES                
Convertible notes payable, net           270,000  
Convertible notes payable-related party, net           30,000  
TOTAL LONG TERM LIABILITIES           300,000  
                 
TOTAL LIABILITIES     593,926       747,379  
Preferred Stock, 10,000,000 shares authorized, $0.0001 par value                
Redeemable preferred stock Series A, 150,000 Designated; $0.0001 Par Value; 112,690 and 0 shares issued and outstanding as at December 31, 2016 and December 31, 2015, respectively     11        
                 
STOCKHOLDERS' DEFICIT                
Common stock 200,000,000 Shares Authorized; $0.001 Par Value; 36,181,101 and 14,353,093 shares issued and outstanding as of December 31, 2016 and December 31, 2015, respectively     36,181       14,353   
Additional paid in capital     1,362,387       73,140  
Accumulated deficit     (1,978,400 )     (783,596 )
Total Stockholders' Deficit     (579,832 )     (696,103 )
Total Liabilities and Stockholders' Deficit   $ 14,105     $ 51,276  

 

The accompanying notes are an integral part of these audited consolidated financial statements.

 

 

 

 

 

  F- 3  

 

 

DTHERA SCIENCES

CONSOLIDATED STATEMENTS OF OPERATIONS

For the Years Ended December 31,

   

 

    2016     2015  
REVENUES                
Sales            
Cost of services            
GROSS PROFIT            
                 
OPERATING EXPENSES                
Deprecation and amortization     6,159       915  
General and administrative     690,248       590,569  
Professional fees     343,694       156,573  
TOTAL OPERATING EXPENSES     1,040,101       748,057  
                 
OPERATING LOSS     (1,040,101 )     (748,057 )
                 
OTHER EXPENSES                
Interest expense     (126,115 )     (21,350 )
Derivative expense     (37,616 )      
Gain on derivative liability     33,114        
Gain on settlement of debt     34,874        
Impairment of intangible assets     (58,960 )     (7,100 )
TOTAL OTHER EXPENSES     (154,703 )     (28,450 )
                 
Provision for Income Taxes            
                 
NET LOSS   $ (1,194,804 )   $ (776,507 )
                 
Loss per share
   Basic and diluted
  $ (0.05 )   $ (0.06 )
WEIGHTED AVERAGE SHARES OUTSTANDING
   Basic and diluted
    23,767,632       11,971,621  

 

 

The accompanying notes are an integral part of these audited consolidated financial statements.

 

 

 

  F- 4  

 

 

DTHERA SCIENCES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

   

 

                  Additional       Total  
  Preferred Stock   Common Stock   Paid   Accumulated   Stockholders'  
  Shares   Amount   Shares   Amount   in Capital   Deficit   Deficit  
Balance December 31, 2014     $     7,701,659   $ 7,702   $ 2,298   $ (7,089 ) $ 2,911  
                                           
Common stock issued for cash           6,301,358     6,301     3,699         10,000  
Common stock issued for services           350,076     350     33,150         33,500  
Fair value of options vested                   33,993         33,993  
Net loss for the year ended December 31, 2015                       (776,507 )   (776,507 )
                                           
Balance December 31, 2015           14,353,093     14,353     73,140     (783,596 )   (696,103 )
                                           
Common stock issued for cash           314,500     315     62,585         62,900  
Common stock issued for services           438,363     438     41,437         41,875  
Common stock issued for patent           616,133     616     58,344         58,960  
Common stock issued for conversion of debt           4,388,997     4,389     725,785         730,174  
Common stock issued in lieu of interest           70,015     70     6,630         6,700  
Preferred stock issued for conversion of debt   112,690     11             112,679         112,679  
Fair value of options vested                   241,433         241,433  
Common stock issued in share exchange agreement           16,000,000     16,000     40,354         56,354  
Net loss for the year ended December 31, 2016                       (1,194,804 )   (1,194,804 )
                                           
Balance December 31, 2016   112,690   $ 11   $ 36,181,101   $ 36,181   $ 1,362,387   $ (1,978,400 ) $ (579,832 )

 

The accompanying notes are an integral part of these audited consolidated financial statements.

 

 

 

  F- 5  

 

 

DTHERA SCIENCES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended December 31,

   

 

    2016     2015  
             
CASH FLOWS FROM OPERATING ACTIVITIES                
Net Loss   $ (1,194,804 )   $ (776,507 )
Adjustments for non-cash items:                
Amortization and depreciation     73,505       4,272  
Impairment of intangible assets     58,960       7,100  
Common stock issued for services     16,750       33,500  
Loss on extinguishment of debt     (34,874 )      
Gain on derivative liability     (33,114 )      
Initial derivative expense     37,616        
Fair value of stock options vested     241,433       33,993  
Operating expenses paid on behalf of the company by related parties     20,627       69,499  
Changes in operating assets and liabilities:                
Prepaid expenses     21,390       (21,390 )
Deposits           (1,000 )
Accounts payable and accrued liabilities     291,891       148,556  
Accrued interest     58,773       17,993  
NET CASH USED IN OPERATING ACTIVITIES     (441,847 )     (483,984 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES                
Property and equipment           (2,166 )
Intangible assets           (7,100 )
NET CASH USED IN INVESTING ACTIVITIES           (9,266 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES                
Proceeds from issuance of common stock     62,900       10,000  
Proceeds from issuance of notes payable     20,000        
Proceeds from issuance of notes payable - related party           135,000  
Proceeds from issuance of convertible notes     330,000       456,333  
Proceeds from issuance of notes payable - related party     94,000        
Proceeds from issuance of convertible notes - related party           58,667  
Payments of notes payable - related party     (80,100 )     (148,153 )
NET CASH PROVIDED BY FINANCING ACTIVITIES     426,800       511,847  
                 
NET CHANGE IN CASH AND CASH EQUIVALENTS     (15,047 )     18,597  
                 
CASH AND CASH EQUIVALENTS                
Beginning of period     27,238       8,641  
                 
End of period   $ 12,191     $ 27,238  
                 
NON-CASH INVESTING AND FINANCING ACTIVITIES                
Shares issued for assets   $ 58,960     $  
Common stock issued for accrued interest   $ 6,700     $  
Preferred series A shares issued in settlement of debt   $ 112,690     $  
Shares issued in settlement of debt   $ 731,391     $  
Net liabilities assumed in share exchange agreement   $ 56,354     $  
Debt discounts on convertible debt   $ 240,000     $ 10,000  

 

The accompanying notes are an integral part of these audited consolidated financial statements.

 

 

 

  F- 6  

 

 

DTHERA SCIENCES

(FKA Knowledge Machine International, Inc.)

Notes to Consolidated Financial Statements

December 31, 2016 and 2015

 

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Description of Business

Dthera Sciences (formerly Knowledge Machine International, Inc.) is a Nevada corporation, and was incorporated on December 27, 2012.

 

The Company offers a subscription-based service that captures, shares, and stores photos and audio in cloud. It offers a proprietary platform (the “Platform”), which enables users to preserve and share memories, and will initially target a Quality of Life benefit in certain patient populations, principally patients suffering from Alzheimer’s disease and dementia. On September 21, 2016, the Company acquired a new operating subsidiary, EveryStory, Inc., a Delaware corporation (“EveryStory”). Following the acquisition (referred to herein as the “EveryStory Transaction”), the Company’s business is to develop a Digital Therapeutic technology designed to deliver Reminiscence Therapy to certain patient populations, principally patients suffering from Alzheimer’s disease and dementia with the goal of a Quality of Life benefit and reduction in anxiety in those populations. As of the date of this Report, EveryStory was our only subsidiary. In connection with the EveryStory Transaction, the Company dissolved its other former subsidiary entity and terminated its prior business operations.

 

Acquisition of EveryStory; EveryStory Transaction

 

On September 21, 2016, the Company entered into an Amended and Restated Acquisition and Share Exchange Agreement (the “A&R Agreement”) with EveryStory, Inc., a Delaware corporation (“EveryStory”), and each of its shareholder (the “Shareholders”), and closed the acquisition (the “Acquisition”) of the ownership of EveryStory (the “Closing”).

 

The Company acquired all of the outstanding shares of EveryStory, and agreed to issue an aggregate of 77,377,713 pre-split /15,477,604 post-split shares of the Company’s common stock to the EveryStory holders, with the understanding that an additional 21,942,062 pre-split/4,388,997 post-split shares were issued to holders of EveryStory convertible debt instruments which are convertible or exercisable into shares of EveryStory common stock (collectively, the “Exchange Shares”). Additionally, prior to Closing, the parties agreed that certain shares of the Company’s common stock were to be returned to the Company for cancellation, resulting in the current Company’s shareholders owning an aggregate of 40,875,000 pre-split/8,000,000 post-split shares of the Company’s common stock immediately prior to the Closing.

 

Pursuant to the A&R Agreement, the 99,319,775 pre-split/ 19,866,601 post-split Exchange Shares issued or to be issued to the EveryStory constituted 75% of the total issued and outstanding shares of the Company’s common stock, and the legacy Company shareholders (who were the owners of the Company’s common stock immediately prior to the Closing) owned an aggregate of 40,875,000 shares, which constituted 25% of the total outstanding Company common stock.

 

The Company’s and EveryStory’s management agreed, and the A&R Agreement provides, that following the Closing, the Company will conduct a reverse stock split (discussed in more detail below), following which the outstanding shares of the Company’s Series A Preferred Stock will convert into a total of 8,000,000 post-reverse-split common stock. Following such conversion, the EveryStory owners will own or have the right to receive shares of the Company’s common stock equal to 55% of the then-outstanding Company common stock, and the Company legacy shareholders will own shares of the Company’s common stock equal to 45% of the then-outstanding Company common stock, consisting of 8,000,000 shares of Company common stock issued on conversion of the Company’s Series A Preferred Stock (22.5%) and 8,000,000 shares of the Company’s common stock owned by the other legacy Company shareholders (22.5%).

 

As a result of the Closing of the A&R Agreement, EveryStory became our wholly owned subsidiary. Additionally (as discussed more fully below), our directors and officers immediately prior to the Closing appointed the EveryStory management to become our new officers and directors, and then resigned from their positions with us. In addition, we terminated our pre-closing business operations and agreed to dissolve our other wholly owned subsidiary, Knowledge Machine.

 

Immediately prior to the Closing, there were 40,875,000 shares of the Company’s common stock. In connection with the Closing, the Company issued an aggregate of 77,377,713 pre-split/ 15,477,604 post-split shares to the EveryStory shareholders, and 21,942,062 pre-split/4,388,997 post-split shares were issued to the holders of EveryStory convertible debt instruments, and the parties to the A&R Agreement understand and anticipate that all such holders would exercise and convert their securities into the reserved shares of the Company.

 

 

 

  F- 7  

 

 

On November 2, 2016, a reverse stock split (the “Reverse Split”) of the Company’s common stock took effect. The ratio of the Reverse Split was 1:5.109375, meaning one new share for each 5.109375 old shares of the Company’s common stock. Except as specifically noted or indicated herein, all share numbers provided in this Annual Report are given on a post-reverse-split basis.

 

Accounting Basis

The Company’s financial statements are prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).   As disclosed in a Current Report on Form 8-K filed November 17, 2016, the Company recently changed to a December 31 fiscal year end.

 

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates are made in relation to the allowance for doubtful accounts and the fair value of certain financial instruments.

 

Principles of Consolidation

The consolidated financial statements include the accounts of Dthera Sciences and its subsidiaries. All significant inter-company accounts and transactions have been eliminated.

 

Cash and Cash Equivalents

Cash and cash equivalents include all cash balances and highly liquid investments with an original maturity of three months or less. As of December 31, 2016 and 2015, the Company’s cash balances were within the FDIC insurance coverage limits.

 

Fair Value of Financial Instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

 

The following are the hierarchical levels of inputs to measure fair value:

 

  Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
   
  Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
   
  Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

 

The Company accounts for its derivative liabilities and non-employee stock options, at fair value, on a recurring basis under level 2.

 

Embedded Conversion Features

The Company evaluates embedded conversion features within convertible debt under Accounting Standards Codification (“ASC”) 815, "Derivatives and Hedging" to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 "Debt with Conversion and Other Options" for consideration of any beneficial conversion feature.

 

 

 

  F- 8  

 

 

Derivative Financial Instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase options and convertible debt, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.

 

For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

 

For convertible debt with embedded derivatives, the Company uses the Binomial Lattice model to value the embedded derivatives.

  

Debt Issuance Costs and Debt Discount

The Company may record debt issuance costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.

 

Concentration of Risk

Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash.  Our cash balances are maintained in accounts held by major banks and financial institutions located in the United States. The Company occasionally maintains amounts on deposit with a financial institution that are in excess of the federally insured limits. The risk is managed by maintaining all deposits in high quality financial institutions.

 

For the year ended December 31, 2016 and 2015 there were no customers that accounted for a material portion of total revenues.  

 

Property and Equipment

Property and equipment is recorded at cost less accumulated depreciation. Depreciation and amortization is calculated using the straight-line method over the expected useful life of the asset, after the asset is placed in service. The Company generally uses the following depreciable lives for its major classifications of property and equipment:

 

Description Useful Lives
Office Equipment and Computers 2 to 3 years

 

Expenditures associated with upgrades and enhancements that improve, add functionality, or otherwise extend the life of property and equipment are capitalized, while expenditures that do not, such as repairs and maintenance, are expensed as incurred.

 

Valuation of Long-Lived Assets

Long-lived tangible assets and definite-lived intangible assets are reviewed for possible impairment annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company uses both an estimate of undiscounted future net cash flows of the assets over the remaining useful lives and a replacement cost method when determining their fair values. If the carrying values of the assets exceed the fair value of the assets, the Company recognizes an impairment loss equal to the difference between the carrying values of the assets and their fair values. Impairment of long-lived assets is assessed at the lowest levels for which there are identifiable cash flows that are independent from other groups of assets. The evaluation of long-lived assets requires the Company to use estimates of future cash flows. However, actual cash flows may differ from the estimated future cash flows used in these impairment tests.

 

Revenue Recognition

The Company recognizes revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered to the customer, (iii) the fee is fixed or determinable, and (iv) collectability is reasonably assured. Where arrangements have multiple elements, revenue is allocated to the elements based on the relative selling price method and revenue is recognized based on the Company’s policy for each respective element.

 

 

 

  F- 9  

 

 

Software Development

The Company accounts for internal use software development costs in accordance with authoritative guidance related to accounting for the costs of app and web software developed or obtained for internal use. Software development costs that are incurred in the preliminary development stage are expensed as incurred. Once certain criteria have been met (“application development stage”), direct costs incurred in developing or obtaining computer software are capitalized. Costs in the post-implementation/operation stage, including costs related to training and software maintenance, are expensed as incurred.

 

Research and Development

The Company engages in new software development efforts. Research and development expenses relating to possible future software are expensed as incurred. Research and development expenses were approximately $0 for the years ended December 31, 2016 and 2015.

 

Advertising Expenses

The Company expenses advertising costs as incurred. Advertising may consist of media or online advertising and marketing. As such, advertising expenses were approximately $86,037 and $85,049 for the years ended December 31, 2016 and 2015, respectively.

 

Stock-Based Compensation

The Company accounts for share based payments in accordance with Accounting Standards Codification (“ASC”) 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective – Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For this purpose, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders.

 

Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.

 

ASC 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this transition method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.

 

Loss Per Share

Basic loss per Common Share is computed by dividing losses attributable to Common shareholders by the weighted-average number of shares of Common Stock outstanding during the period.

 

Diluted loss per Common Share is computed by dividing loss attributable to Common shareholders by the weighted-average number of Shares of Common Stock outstanding during the period increased to include the number of additional Shares of Common Stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding convertible Preferred Stock, stock options, warrants, and convertible debt. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s Common Stock can result in a greater dilutive effect from potentially dilutive securities.

 

For the years ended December 31, 2016 and 2015, all of the Company’s potentially dilutive securities (options and convertible debt) were excluded from the computation of diluted earnings per share as they were anti-dilutive. The total number of potentially dilutive Common Shares that were excluded were 3,596,198 and 741,418 at the years ended December 31, 2016 and 2015, respectively.

 

Income Taxes

The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The charge for taxation is based on the results for the year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

 

 

 

  F- 10  

 

 

In July 2006, the Financial Accounting Standards Board (“FASB”) issued ASC 740,  Accounting for Uncertainty in Income Taxes , which clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a return. ASC 740 provides guidance on the measurement, recognition, classification and disclosure of tax positions, along with accounting for the related interest and penalties. Under this pronouncement, the Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of the last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority.

 

The Company’s policy is to recognize both interest and penalties related to unrecognized tax benefits in income tax expense. Interest and penalties on unrecognized tax benefits expected to result in payment of cash within one year are classified as accrued liabilities, while those expected beyond one year are classified as other liabilities. The Company has not recorded any interest and penalties since its inception.

 

The Company files income tax returns in the U.S. federal tax jurisdiction and various state tax jurisdictions. The tax years for 2013 to 2016 remain open for federal and/or state tax jurisdictions. The Company is currently not under examination by any other tax jurisdictions for any tax years.

 

Recent Accounting Pronouncements

Management has considered all other recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

 

NOTE 2 – GOING CONCERN

 

The Company's financial statements are prepared using U.S. GAAP applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. As of the date of this Report, the Company had an accumulated deficit of $1,978,400, negative working capital of $580,735, and no revenues to cover its operating costs, which raises substantial doubt about its ability to continue as a going concern. As of the date of this Report, the Company had not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern.

 

The future of the Company as an operating business will depend on its ability to (1) obtain sufficient capital contributions and/or financing as may be required to sustain its operations, and (2) to achieve adequate revenues from its operations. Management's plan to address these issues includes, (a) continued exercise of tight cost controls to conserve cash, (b) obtaining additional financing, (c) placing revenue producing services into place, and (d) identifying and executing on additional revenue generating opportunities.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

 

NOTE 3 – PROPERTY AND EQUIPMENT

 

The Company’s property and equipment were comprised of the following as of December 31, 2016 and 2015:

 

    December 31,
2016
    December 31,
2015
 
Computer and Equipment     2,816       2,816  
Less: Accumulated Depreciation     (1,902 )     (1,168 )
Net Property and Equipment   $ 914     $ 1,648  

 

NOTE 4 – ASSET ACQUISITION

 

On June 5, 2016, EveryStory  issued  88,000 shares of its common stock, which exchanged for 616,133 shares of Dthera common stock, for the purchase agreement for an SIT Patent at $0.67 per share for a value of $58,960. The price per share for Common Stock issued was based on the relative fair market value of the Common Stock using the backsolve valuation method.

 

 

 

  F- 11  

 

 

The Company evaluated this acquisition in accordance with ASC 805, Business Combinations (10-55-4) to discern whether the assets and operations of SIT met the definition of a business. The Company concluded there were not a sufficient number of key processes obtained to develop the inputs into outputs, nor could such processes be easily obtained by the Company. Accordingly, the Company accounted for this transaction as the acquisition of assets.

 

The transaction was accounted for in accordance with asset acquisition guidance found in ASC 805. The consideration transferred and assets acquired recognized is as follows:

 

Consideration paid:      
Common Stock   $ 58,960  
         
Consideration received:        
Intangible assets   $ 58,960  
         
Net value of assets purchased:   $ 58,960  

 

NOTE 5 – INTANGIBLE ASSETS

 

The Company’s intangible assets were comprised of the following of December 31, 2016 and 2015:

 

    December 31,
2016
    December 31,
2015
 
Technology asset purchase   $ 58,960     $ 7,100  
Less: Accumulated Amortization            
Less: Impairment     (58,960 )     (7,100 )
Net Intangible Assets   $     $  

 

The Company impaired intangible assets related to the technology asset purchase and patent purchase due to no revenue production, totaling $58,960 and $7,100, for the years ended December 31, 2016 and 2015, respectively.

  

NOTE 6 – LOANS PAYABLE

 

Notes Payable – Related Parties

 

Notes payable due to related parties consisted of the following as of December 31, 2016 and 2015:

 

Balance December 31, 2015   $ 61,064  
Cash additions     94,000  
Expense additions     20,627  
Cash payments     (80,100 )
Conversions     (95,591 )
Balance December 31, 2016   $  

 

During the years ended December 31, 2016 and 2015, EveryStory’s Founder and CEO advanced $88,000 and $110,000, and expense additions of $20,627 and $68,904, and was repaid $66,000 and $75,000, respectively. The notes bear an interest rate of 0% per annum.

 

During the years ended December 31, 2016 and 2015, EveryStory’s Founder and CTO advanced $6,000 and $25,000, and expense additions of $0 and $595, and was repaid $14,100 and $73,153, respectively. The notes bear an interest rate of 0% per annum.

 

 

 

  F- 12  

 

 

On September 21, 2016, the Company’s wholly owned subsidiary (EveryStory) issued 112,690 shares of the EveryStory Series A Preferred Stock to the CEO and CTO in exchange for and as full payment of amounts to them which included $6,096 of accrued expenses, $95,591 of related party loans, $10,000 of convertible notes payable and $1,003 of accrued interest on the convertible notes payable. The EveryStory Series A Preferred Stock are redeemable at any time for cash on a dollar-per-dollar basis at a redemption price of $1.00 per share. If not redeemed for cash, the shares of EveryStory Series A Preferred Stock can be convertible into shares of common stock, using a post-split conversion price of $0.10 per share pursuant to the A&R Agreement.

 

Notes Payable

 

Notes payable consisted of the following as of December 31, 2016 and 2015:

 

Balance December 31, 2015   $  
Cash additions     20,000  
Expense additions      
Cash payments      
Conversions      
Balance December 31, 2016   $ 20,000  

 

On August 3, 2016, the Company entered into a promissory note purchase agreement with an unrelated individual for $20,000. This note is due on demand. In lieu of interest, EveryStory  issued  10,000 shares of its common stock, which exchanged for 70,015 shares of Dthera common stock, for a value of $6,700.

 

Convertible Notes Payable  –  Related Parties

 

Convertible notes payable due to related parties consisted of the following as of December 31, 2016 and 2015:

 

Balance December 31, 2015   $ 60,000  
Cash additions      
Expense additions      
Conversions     (60,000 )
Debt discount from debt issuance costs      
Balance December 31, 2016   $  

 

On June 29, 2015, EveryStory issued to two related party individuals convertible notes for $30,000 that mature on December 31, 2016. The notes bear an interest rate of 12% per annum and are convertible into shares of EveryStory’s common stock at the lesser of 70% of the price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $2,000,000 divided by the fully diluted capitalization of the Company immediately prior to the closing date of the qualified financing.

 

On November 18, 2015, EveryStory issued to two related party individuals convertible notes for $30,000 that mature on November 18, 2017. The notes bear an interest rate of 12% per annum and are convertible into shares of EveryStory’s common stock at the lesser of 60% of the lowest price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $5,000,000 divided by the fully diluted capitalization of EveryStory immediately prior to the closing date of the qualified financing.

 

On September 21, 2016, in connection with the EveryStory Transaction and the A&R Agreement, the Company's CEO converted the full balance of notes totaling $10,000 of principal and $1,003 of interest into series A preferred stock, and a director of the Company converted $50,000 of principal and $6,231 of interest into an aggregate of 337,998 shares of Dthera common stock.

 

 

 

  F- 13  

 

 

Convertible Notes Payable  

 

Notes payable due to non-related parties consisted of the following as of December 31, 2016, and December 31, 2015:

 

 

Balance December 31, 2015   $ 465,000  
Cash additions     330,000  
Expense additions     10,000  
Conversions     (565,000 )
Debt discount     (172,655 )
Balance December 31, 2016   $ 67,345  

 

On June 29, 2015, EveryStory issued to ten unrelated individuals convertible notes in the aggregate amount of $195,000 that mature on December 31, 2016. The notes bear an interest rate of 12% per annum and are convertible into shares of EveryStory’s common stock at the lesser of 70% of the price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $2,000,000 divided by the fully diluted capitalization of EveryStory immediately prior to the closing date of the qualified financing. On September 21, 2016, all of these convertible notes were converted into common stock based on the terms of the A&R Agreement.

 

On October 20, 2015, EveryStory issued to an unrelated individual a convertible note for $5,000 that matures on October 20, 2017. The note bears an interest rate of 12% per annum and is convertible into shares of EveryStory’s common stock at the lesser of 60% of the lowest price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $5,000,000 divided by the fully diluted capitalization of EveryStory immediately prior to the closing date of the qualified financing. On September 21, 2016, this convertible note was converted into common stock based on the terms of the A&R Agreement.

 

On November 18, 2015, EveryStory issued to eleven unrelated individuals convertible notes in the aggregate amount of $265,000 that mature on November 18, 2017. The notes bear an interest rate of 12% per annum and are convertible into shares of EveryStory’s common stock at the lesser of 60% of the lowest price per share paid by the investors for the next preferred stock in a qualified financing or the quotient of $5,000,000 divided by the fully diluted capitalization of EveryStory immediately prior to the closing date of the qualified financing. On September 21, 2016, all of these convertible notes were converted into common stock based on the terms of the A&R Agreement.

 

On February 9, 2016, EveryStory issued to an unrelated individual two convertible notes for $100,000 that mature on February 9, 2018. The notes bear an interest rate of 0% per annum and are convertible into shares of EveryStory’s common stock at the $1.60 per share. On September 21, 2016, these convertible notes were converted into common stock based on the terms of the A&R Agreement.

 

On September 21, 2016, in connection with the EveryStory Transaction and the A&R Agreement, note holders converted their convertible notes in the aggregate amount of $565,000 and interest totaling $56,256 into an aggregate of 3,726,981 shares of Dthera common stock.

 

Effective September 22, 2016, the Company conducted a private offering of convertible notes (the “ Note Offering ”) to raise additional capital that would remain in the Company following the Closing of the EveryStory Transaction. In the convertible note offering, the Company raised an aggregate of $240,000, which was to be a component of the post-Closing capitalization of the Company. In the Note Offering, investors entered into a securities purchase agreement (the “ Note SPA ”) and were issued a convertible redeemable promissory note (collectively, the “ Convertible Notes ”). Pursuant to the terms of the Note SPA, each investor represented and warranted that it was an accredited investor and that he or she was purchasing the Convertible Notes for his or her own account, and not with a view to distribution, as well as other standard representations made in private transactions. Also pursuant to the Note SPA, the Company has the right to put an additional Convertible Note (in the same principal amount as purchased by the applicable investor) beginning on January 3, 2017, subject to certain conditions. The Convertible Notes bore interest at a rate of 10%, and were to mature on September 13, 2017, if not converted or prepaid prior to that. The Convertible Notes could convert into shares of the Company's common stock at a price for each share of Common Stock equal to 65% of the lowest closing bid price of the Common Stock as reported on the OTC Market platform on which the Company’s shares are quoted or any exchange upon which the Common Stock may be traded in the future ("Exchange"), on the date of the closing of the EveryStory Transaction. Up to 50% of the Convertible Notes could be repaid by the Company any time prior to 180 days after the issuance of the Convertible Notes, with a 30% premium to be paid in connection with the prepayment. As a result of this transaction a debt discount of $240,000 was recorded against the note. As of December 31, 2016, interest expense of $67,345 was recorded as part of the amortization of the debt discount, leaving a debt discount balance of $172,655. The principal balance of these notes at December 31, 2016 were $240,000.

 

 

 

 

  F- 14  

 

NOTE 7 –DERIVATIVE LIABILITIES

 

The Company evaluates its fair value hierarchy disclosures each quarter. The Company has convertible debentures with embedded conversion features, which is accounted for as a derivative liability and measured at fair value on a recurring basis. As of December 31, 2016 this derivative liability had an estimated fair value of $234,502.

 

The following table presents information about our derivative liability, which was our only financial instrument measured at fair value on a recurring basis using significant inputs other than level one inputs that are either directly or indirectly observable (Level 2) as of  December 31, 2016:

  

Balance at December 31, 2015   $  
Additions related to embedded conversion features     267,616  
Change in Fair Value of Derivative     (33,114 )
Balance at December 31, 2016   $ 234,502  

 

The fair value of this derivative liability was calculated using the Binomial Lattice model, valuing the derivative liability within the notes based on a probability weighted discounted cash flow model. These models are based on future projections of the various potential outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion feature with the reset provisions; redemption provisions; and the default provisions. Assumptions used to calculate the fair value of the derivative liability were as follows:

 

    December 31,
    2016
Expected term in years   0.98 – 0.70 years
Risk-free interest rates   0.56 – 0.71%
Volatility   166.9 – 188.4%
Dividend yield   0%

 

 

NOTE 8 –PREFERRED STOCK

 

The Company has authorized 10,000,000 Preferred Stock, of which it has designated 150,000 shares of $0.0001 par value per share Series A Redeemable Preferred Stock. The Series A Preferred Stock has a stated value of $1.00 per share, of which 112,690 and 0 shares were issued and outstanding as of December 31, 2016 and 2015, respectively.

 

On September 13, 2016, the Company issued 112,690 shares of A Preferred Stock to the CEO and CTO in exchange for amounts owed to them which included $6,096 of accrued expenses, $95,591 of related party loans, $10,000 of convertible notes payable and $1,003 of accrued interest on the convertible notes payable. The Series A Preferred stock are redeemable at any time for cash on a dollar-per-dollar basis at a redemption price of $1.00 per share. If not redeemed for cash, according to the A&R Agreement the shares of Series A Preferred Stock can be converted into shares of Common Stock using a post-split conversion price of $0.10 per share pursuant to the A&R Agreement.

 

 

 

  F- 15  

 

 

Series A Redeemable Preferred Stock

 

The Series A Preferred Stock have the following rights and preferences:

 

  · Redeemable at any time at the option of the holder for cash on a dollar-per-dollar basis at a redemption of $1.00 per share.

 

  · Convertible into shares of Common Stock using a conversion price of $0.10 per share.

 

  · No general voting rights until converted into Common Stock.

 

  · Entitled to receive dividends at a rate per annum of 8%

 

  · Liquidation preference upon a liquidation event.

 

NOTE 9 – COMMON STOCK

 

The Company has authorized 200,000,000 shares of $0.001 par value per share Common Stock, of which 181,069,775 pre-split/36,181,101 post-split shares and 14,353,093 shares were issued outstanding as of December 31, 2016, and December 31, 2015, respectively.

 

Year Ended December 31, 2016

 

On June 5, 2016, EveryStory issued 88,000 shares of its common stock, which were exchanged for 616,133 shares of Dthera common stock for the purchase agreement for an SIT Patent for a value of $58,960.

 

On August 3, 2016, EveryStory  issued  10,000 shares of its common stock, which exchanged for 70,015 shares of Dthera common stock, for a value of $6,700 of accrued interest.

 

On September 15, 2016, EveryStory issued 25,000 shares of its common stock, which were exchanged for 175,038 shares of Dthera common stock valued at $16,750 for services .

 

On September 16, 2016, EveryStory issued 37,500 shares of its common stock, which were exchanged for 263,325 shares of Dthera common stock valued at $25,125 in settlement of $60,000 of accrued consulting fees . This resulted in a gain on settlement of $34,875.

 

On September 21, 2016, as part of the A&R Agreement, EveryStory issued 625,033 shares of its common stock, which were exchanged for 4,388,997 shares of Dthera common stock, for the conversion of debt for a value of $730,174. In connection with the A&R Agreement, the parties agreed that the prior shareholders of the Company would own an aggregate of 16,000,000 post-split shares of the Company’s common stock as part of the agreement totaling $56,354. The reverse stock split is discussed in more detail in Note 1 above.

 

From November to December 2016 the Company issued 314,500 shares of common stock at $0.20 per share for cash proceeds of $62,900, pursuant to the private placement offering.

 

Year Ended December 31, 2015

 

EveryStory issued 900,000 shares of its common stock for net cash proceeds of $10,000 to EveryStory founders. EveryStory also issued 50,000 shares of its common stock for services valued at $33,500. The price per share for Common Stock issued for services was based on the relative fair market value of the Common Stock using the backsolve valuation method. As of December 31, 205 there was 2,050,000 shares of EveryStory stock issued and outstanding. On September 21, 2016, as part of the A&R Agreement, these shares were exchanged for 14,353,093 shares of Dthera common stock.

 

 

 

  F- 16  

 

 

NOTE 10 – STOCK PURCHASE OPTIONS

 

In 2015, the Board of Directors of EveryStory approved the adoption of the EveryStory’s Stock Option Plan (“the Plan”). The purpose of the Plan is to advance the interests of EveryStory by encouraging and enabling acquisition of a financial interest in EveryStory by employees, consultants, and other key individuals. The Plan is intended to aid EveryStory in attracting and retaining key employees, to stimulate the efforts of such individuals and to strengthen their desire to remain with EveryStory. A maximum of 680,000 shares of EveryStory's Common Stock is reserved for issuance under stock options to be issued under the Plan. The Plan permits the grant of incentive stock options, non-statutory stock options and restricted stock awards. The Plan is administered by the Board of Directors or, at its direction, a Compensation Committee comprised of officers of EveryStory. 

 

Stock Purchase Options

 

During the year ended December 31, 2016, EveryStory issued non-employee options to purchase a total of 106,100 shares of EveryStory common stock, which would exchange for 742,860 shares of Dthera common stock, which were originally valued at $63,678. EveryStory issued the options in conjunction with services. The EveryStory options were converted into Dthera options on September 21, 2016, pursuant to the A&R Agreement. As the options holders are non-employees, the values attributable to these options are remeasured on a quarterly basis and amortized over the service period and until they have fully vested over a 3 year vesting period. The Company believes that the fair value of the stock options is more reliably measurable than the fair value of the services received. The fair value of the stock options granted were revalued at each reporting date using the Black-Scholes valuation model. As of December 31, 2016, the company remeasured the options at a value of $1,609,669 to be recognized over the vesting period, of which $199,969 has been recognized.

 

During the year ended December 31, 2015, EveryStory issued options to purchase a total of 486,200 shares of EveryStory common stock, which would exchange for 3,404,134 shares of Dthera common stock, valued at $75,457 with multiple vesting periods. The options were valued using the Black-Scholes options pricing model under the assumptions noted below. The price per share for Common Stock for the stock options was based on the relative fair market value of the Common Stock using the backsolve valuation method of applying the Option Pricing Method (OPM). The options were converted into Dthera options on September 21, 2016, pursuant to the A&R Agreement. Further, according to the option agreements entered into in 2015, these options vested immediately when EveryStory Options converted to Dthera options.

 

The following table summarizes the changes in options outstanding of the Company during the year ending December 31, 2016:

 

    Number of
Options
    Weighted
Average
Exercise
Price $
 
Outstanding, December 31, 2015     3,404,134       0.10  
Granted     742,860       0.10  
Exercised            
Outstanding, December 31, 2016     4,146,994       0.10  
                 
Exercisable, December 31, 2016     3,404,134       0.10  

 

Stock option expense of $241,433 and $33,993 was recorded in the years ended December 31, 2016 and December 31, 2015, respectively. Total remaining unrecognized compensation cost related to unvested stock options is approximately $1,409,700 and is expected to be recognized over a period of 2.67 years.

 

 

 

 

  F- 17  

 

 

NOTE 11 – INCOME TAXES

 

There was no provision for, or benefit from, income tax during the years ended December 31, 2015 and 2014 respectively. The components of the net deferred tax asset as of December 31, 2016 and 2015:

 

    December 31,
2016
    December 31,
2015
 
Operating loss carry forwards   $ 672,656     $ 266,423  
Depreciation & amortization     (2,480 )     (386 )
Loss on impairment     (22,460 )     (2,414 )
Stock-based compensation     (117,416 )     (21,091 )
Total Deferred Tax Assets     530,300       242,532  
Valuation allowance     (530,300 )     (242,532 )
Net Deferred Tax Asset   $     $  

 

Federal and state net operating loss carry forwards were $1,978,400 and $783,596 as of December 31, 2016 and 2015, respectively. The net operating loss carry forwards expire between 2033 and 2036.

 

The following is a reconciliation of the amount of benefit that would result from applying the federal statutory rate to pretax loss with the provision for income taxes for the years ended December 31, 2016 and 2015, respectively:

 

    December 31,
2016
    December 31,
2015
 
Tax at statutory rate (34%)   $ (406,233 )   $ (264,012 )
Non-deductible expenses     118,465       23,817  
Change in valuation allowance     287,768       240,195  
State tax benefit, net of federal tax effect            
Provision for Income Taxes   $     $  

 

In June 2006, FASB issued FASB ASC 740-10-05-6. The Company adopted FASB ASC 740-10-05-6 on January 1, 2013. Under FASB ASC 740-10-05-6, tax benefits are recognized only for the tax positions that are more likely than not be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the company's tax return that do not meet these recognition and measurement standards.

 

Upon the adoption of FASB ASC 740-10-05-6, the Company had no liabilities for unrecognized tax benefits and, as such, the adoption had no impact on its financial statements, and the Company has recorded no additional interest or penalties. The Adoption of FASB ASC 740-10-05-6 did not impact the Company's effective tax rates.

  

 

 

  F- 18  

 

 

The Company's policy is to recognize potential interest and penalties accrued related to unrecognized tax benefits with the income tax expense. For the years ended December 31, 2016, and 2015, the Company did not recognize any interest or penalties in its Statement of Operations, nor did it have any interest or penalties accrued in its Balance Sheet at December 31, 2016 and 2016 relating to unrecognized benefits.

 

The tax years 2013 through 2016 remain open to examination for federal income tax purposes and by other major taxing jurisdictions to which the Company is subject.

 

NOTE 12 – FAIR VALUE MEASUREMENTS

 

Liabilities measured at fair value on a recurring basis at December 31, 2016, are summarized as follows: 

  

    Level 1     Level 2     Level 3     Total  
Fair value of options   $     $ 1,609,669     $     $ 1,609,669  
Fair value of derivatives   $     $ 234,502     $     $ 234,502  

 

Fair value is calculated using the Black-Scholes options pricing model for the stock options and the Binomial Lattice model for the derivatives.

 

Liabilities measured at fair value on a recurring basis at December 31, 2015, are summarized as follows: 

  

    Level 1     Level 2     Level 3     Total  
Fair value of options   $     $ 75,457     $     $ 75,457  
Fair value of derivatives   $     $     $     $  

 

Fair value is calculated using the Black-Scholes options pricing model for the stock options.

 

NOTE 13- SUBSEQUENT EVENTS

 

In accordance with ASC 855, Company’s management reviewed all material events through the date of this filing and determined that there were the following material subsequent events to report:

 

In February 2017, the Company issued a short-term note to a related party individual for $50,000 due on demand. The note bore an interest rate of 10% per annum interest within the 90 day period and will increase to 20% interest if not fully paid back within 90 days. On April 9, 2017, the Company paid the full balance of $50,000.

 

In March 2017, the Company repaid convertible notes in the original principal amount of $240,000 (the “Convertible Notes”). The Convertible Notes were issued by the Company shortly before the EveryStory transaction. In connection with the repayment of the Convertible Notes, the Company repaid a total of $240,000 in principal and $18,000 in interest, and agreed to issue 83,300 shares of the Company’s common stock to the holders of the Convertible Notes. The shares of stock were issued pursuant to Section 4(a)(2) of the Securities Act of 1933 and regulations promulgated thereunder. Each of the holders of the Convertible Notes represented to the Company that it was an accredited investor, that it was acquiring the shares for its own account and for investment purposes, and not with an intent to distribute.

 

From January through March 2017, pursuant to the private placement offering (the “Private Offering”) the Company issued 6,805,000 shares of common stock for gross proceeds of approximately $1,171,000. The Company’s management intends to use the proceeds to repay certain convertible debt instruments and to use the proceeds for general corporate purposes and working capital.

 

 

  F- 19  

 

Dthera Sciences (GM) (USOTC:DTHR)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Dthera Sciences (GM) Charts.
Dthera Sciences (GM) (USOTC:DTHR)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Dthera Sciences (GM) Charts.